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Abstract 
The Mre11-Rad50-Nbs1 (MRN) protein complex is a well known sensor of DNA 
damage, functioning in signaling pathways that activate cell cycle checkpoints. The 
function of Mre11 is also known to be important for homologous recombination repair 
(HRR), and recent studies have shown that this protein may function both in HRR, as 
well as in the classical pathway of non homologous end joining that utilizes in 
addition to DNA-PK (D-NHEJ) also Ku and the Ligase IV/XRCC4 complex. Indeed, in 
yeast, in addition to Ku and Ligase IV homologs, also the MRN homologs are 
implicated in NHEJ. The Ku70/80 heterodimer is among the first proteins that 
recognize and bind to DNA ends. The crystal structure of Ku reveals an asymmetric 
ring conformation allowing the threading of the DNA and possibly facilitating 
rejoining. After completion of end joining, however, the protein will remain trapped on 
the DNA. This mode of action generates the question as to how trapped Ku is 
released from the DNA, and as to whether trapped protein serves somehow to the 
development of a full-blown DNA damage response. Hitherto, only one report 
suggests a ubiquitin-dependent removal and degradation of Ku80 from DNA, which is 
independent of the completion of NHEJ. There are no reports published to date 
investigating a functional role for the trapped Ku protein in the ensuing DNA damage 
response (DDR) signalling. The present thesis tests the hypothesis that trapped Ku 
contributes to DDR signalling by somehow facilitating the recruitment of the MRN 
complex to the site of the DSB. In support of this hypothesis, we demonstrate here 
that the constitutive interaction between Mre11 and Ku is enhanced after exposure to 
IR and that this enhancement is dose dependent. The interaction between Mre11 
and Ku is studied by immunoprecipitation (IP) from nuclear extracts using an anti-
Ku70 antibody while detecting Mre11 by Western blotting. IP studies are carried out 
using a human alveolar basal epithelium carcinoma cell line (A549), as well as CHO 
cells and a Ku80 deficient mutant (xrs6). As expected, Ku deficient cells show no 
detectable interaction between Mre11 and Ku70 and validate thus the specificity of 
the assay. An interaction between Mre11 and Ku is clearly visible in A549 cells and is 
markedly enhanced after exposure to 2 and 4Gy of X-rays. The interaction is 
resistant to EtBr and RNAase suggesting that it is not mediated by DNA or RNA. 
Rad50 and Nbs1 are also co-precipitated with Mre11, suggesting that the entire MRN 
complex is involved in the interaction. Notably, in addition to MRN, other DNA 
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damage sensors such as PARP-1 and ATM are part of the complex and are co-
precipitated. The results point to intriguing interactions between Ku and 
signaling/repair proteins such as the MRN complex that warrant further investigation. 
The kinetics of Mre11 interaction with Ku after exposure to 4 and 8 Gy X-rays 
showed a weak Mre11 signal at 10 min after irradiation, but a strong signal 1-2 h 
after irradiation. When this interaction was tested in cells defective in PIKK family 
proteins, DNA-PKcs and ATM, it was found that DNA-PKcs defective cells show no 
Ku-MRN interaction following exposure to radiation. Treatment of extracts with 
bacterial alkaline phosphatase led to a decrease in the dose dependent interaction 
between Mre11 and Ku, while treatment with sodium ortho-vanadate and sodium 
azide (inhibitors of protein tyrosine phosphatases) led to an decrease in overall 
interaction but IR-dependent aspect remains unchanged. 
The second part of my thesis focuses on the activity of PARP-1, which is a putative 
component of the backup pathway of non-homologous end joining (B-NHEJ), where 
it may function together with DNA Ligase III and histone H1. Goal of this part of the 
work was to examine possible interactions between Mre11 and PARP-1 and thus to 
establish a possible cross talk between D-NHEJ and B-NHEJ. The results show a 
marked increase in PARP-1 activity with increasing concentration of histone H1. 
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1.  Introduction 
1.1.  DNA damage and repair 
Maintenance of life depends on cell division, in which replication of millions of DNA 
base pairs is required. Proper DNA replication is a prerequisite of faithful 
chromosome segregation. However, once DNA replication faces abnormalities in the 
template DNA, it stops and cellular checkpoints are activated to provide time for 
removal of altered DNA structures. A proper restart of arrested DNA replication is 
vital to prevent activation of programmed cell death. However, the integrity of the 
genome is constantly challenged by endogenous factors, by-products of cellular 
metabolism, like free radicals and exogenous factors such as ionising radiation. DNA 
double strand breaks (DSBs) are one of the most deleterious DNA lesions, which if 
left unrepaired or repaired incorrectly, could lead to chromosomal aberrations 
including dicentrics chromosomes and acentric fragments [1, 2]. Even though DSBs 
is a major threat to genomic integrity, their formation also occurs naturally during 
meiosis [3] and in B and T-lymphocytes during V(D)J and class switch recombination. 
Therefore, the cell has evolved a number of mechanisms to sense, signal and repair 
DSBs that collectively make up the DNA damage response (DDR) [4-6]. 
 
1.2.  The DNA damage Response 
It is known that when inflicted with DNA damage, cells activate an intricate web of 
signalling pathways known as DNA damage response. Upon sensing DNA damage 
or stalled replication forks, cell cycle checkpoints are activated to arrest cell cycle 
progression and to allow time for repair. DDR comprises the stepwise activation of 
protein complexes involved in the detection of DNA lesions, the transduction of the 
generated signal to effector molecules and the activation of different repair pathways 
or of apoptosis (Figure 1). 
DNA DSBs are one of the most powerful activators of DDR and they could be sensed 
by the Ku70/80 heterodimer [7] and the MRN complex [4, 8-10]. If processing of DNA 
ends occurs, the resulting single-stranded DNA (ssDNA) regions are immediately 
coated with RPA, which leads to subsequent activation of another DDR cascade with 
participation of ATR protein kinase [11, 12]. In the following step sensor molecules 
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activate a signal transduction system that involves members of the 
Phosphatidylinositol 3-OH Kinase related kinase family (PIKK) members, ATM, ATR 
[13, 14] and DNA-PKcs [15-17]. Once activated PIKKs phosphorylate many 
downstream targets including the effectors kinases Chk1 and Chk2. Finally the 
activation of cell cycle checkpoints culminates in the abrogation of cell cycle 
progression and the activation of appropriate DNA repair pathways; apoptosis 
ensues if the amount of damaged DNA is significant. 
The key regulators of checkpoint pathways in eukaryotic cells are ATM (Ataxia 
Telangiectasia mutated) and ATR (ATM and Rad3-related) protein kinases. In 
response to initial DNA damage, ATM and ATR are phosphorylated and activate 
many downstream protein targets such as p53, Chk1, Chk2, BRCA1, Rad17, NBS1, 
53BP1, MDC1 and many DNA repair proteins [18, 19]. 
It is commonly assumed that the Mre11-Rad50-Nbs1 (MRN) (Xrs2 in yeast) complex 
is among the earliest molecules sensing DNA damage, particularly DSBs. This 
complex is a paramount component of an entire signalling network and ensures DNA 
repair and activation of cellular response to DSBs. Main function of this complex is to 
recruit the ATM kinase to the damage sites, which considerably increases the ATM 
kinase activity. The requirement of MRN for ATM activation is also consistent with 
upstream MRN activation directly through the DSBs. Poly-ADP-ribose polymerase-1 
(PARP-1) is another cellular enzyme with nuclear localization, which participates in 
sensing of DNA breaks, both single strand and double strand breaks in this case. 
Furthermore, the catalytic subunit of DNA dependent protein kinase (DNA-PKcs) has 
been proposed to be a DNA damage sensor molecule according to its ability to bind 
to DNA ends, either directly or through its interaction with Ku, and its activation by 
DSBs [20]. 
 
1.3.  DNA Repair Pathways 
It has now been conclusively established that cells repair DNA double strand 
breaks primarily by two major pathways: Non-homologous end joining (NHEJ) and 
Homologous recombination (HRR) [21, 22]. Since the classical NHEJ repair pathway 
relies on DNA-PKcs, it is referred as DNA-PKcs-dependent non-homologous end-
joining (D-NHEJ). Other known pathways of DNA DSB repair are single strand 
annealing (SSA) and an alternative or backup pathway of NHEJ (B-NHEJ). All of the 
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above pathways are mechanistically and genetically distinct from each other but their 
functions are complementary and in some ways possibly redundant. 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic diagrammatic representation of DNA damage response [9]: This 
involves myriad of protein complexes. DNA damage is recognised by sensor proteins, which 
activate central signal transducers (for example ATM, a phosphatidylinositol-3-kinase). This 
ultimately results in the activation of effector proteins that execute the functions of DNA 
damage response, including recruitment and activation of checkpoint effectors, DNA repair 
proteins or induction of repair proteins. 
 
1.3.1.  Non-Homologous End-Joining (NHEJ) 
Non-homologous end-joining is an error prone pathway, in which DNA ends are 
directly ligated without need of homologous DNA template. In mammals, NHEJ is 
active throughout the cell cycle but predominates particularly in G0 and G1 phase 
due to non-functional HRR at these cell cycle phases. Mammalian cells favour NHEJ 
pathway [23], although many of the components involved in this pathway are 
conserved from yeast to humans [24, 25]. The big difference is that mammalian cells 
utilize DNA-PKcs in the repair of DSBs by NHEJ, while a homolog of this enzyme in 
yeast and lower eukaryotes has not been found. The importance and usage of this 
repair process also varies greatly among species.  
D-NHEJ involves of the sequential recruitment of protein complexes. In the initial 
step, the Ku70/80 heterodimer binds to DNA ends (initial damage detector) and 
recruits DNA-PKcs to DSBs activating thus its kinase function (Figure 2). DNA-PKcs, 
which displays serine and threonine kinase activity, becomes activated upon DNA 
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end binding, and phosphorylates itself as well as a number of substrates including 
p53, Ku heterodimer, DNA Ligase IV/XRCC4 [26] and replication protein A (RPA2) 
[11], all of which may facilitate NHEJ when phosphorylated. NHEJ of ends with 
damaged nucleotides as well as of more complex non-complementary ends requires 
terminal processing. End processing involves the removal of damaged or 
mismatched nucleotides by nucleases and/or re-synthesis of ssDNA by DNA 
polymerases Pol- and Pol- DNA polymerases Pol- and Pol- (Pol4 in yeast) are 
from Pol-X family of DNA polymerases, which operate at aberrant DNA structures 
and fill the gaps during NHEJ [27]. This step can be skipped if DNA ends are 
compatible for ligation and have a 3’-OH and a 5’ phosphate group.  
There is evidence that the MRN nuclease complex could also participate in this 
reaction to facilitate or to regulate the further ligation step [1, 28], but the exact 
mechanism of engagement remains unknown. Finally, during the third step, the DNA 
Ligase IV/XRCC4 tetramer complex and XLF (Cernunnos) are recruited to ligate the 
DSBs [29-33]. The precise role of XLF is still unknown, but it interacts with DNA 
Ligase IV/XRCC4 and re-adenylates DNA Ligase IV after ligation, thus recharging 
the ligase and allowing it to catalyze a second ligation reaction [34]. BRCA1 and 
BRCA2, the two famous cancer genes, mutations of which are associated with breast 
cancer, are also associated with a number of DNA repair pathways especially NHEJ 
and HRR. 
 
 
 
 
 
 
 
Figure 2: Non-homologous end joining pathway of DNA double strand break repair: 
Step1: Broken DNA ends are recognized by Ku70/80 heterodimer. Ku binds to DNA ends 
and recruits DNA-PKcs. DNA-PK (Ku/DNA-PKcs complex) phosphorylates other proteins 
involved in DNA repair or signaling. Step2: Broken DNA ends are processed to enable 
ligation. Mre11/Rad50/Nbs1 complex may play a role in this step. Step3: DNA Ligase 
IV/XRCC4 is required for stabilization and for maximum activity of DNA Ligase IV [35] . 
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1.3.2.  Homologous recombination repair (HRR) 
Homologous recombination repair (HRR) is an error free pathway, utilizing 
sister chromatid sequences for the restoration of the original DNA sequence in the 
vicinity of the DSB (Figure 3). HRR is particularly important for repairing of DSBs and 
Inter-strand cross links (ICLs) during G2 and S phase of the cell cycle, but it also 
plays an important role in the restoration of stalled or collapsed replication forks [36]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Homologous recombination repair: HRR is an important pathway for repairing 
replication lesions and it depends on the RAD51-family of proteins and makes use of 
homologous DNA sequences normally found in the sister chromatid. The proteins BRCA1 
and BRCA2 play a key role in this pathway [35]. 
 
1.3.3.  Backup (B-NHEJ) or Alternative pathway (A-NHEJ) of NHEJ  
In addition to the DNA-PKcs dependent pathway of NHEJ, cells enlist another NHEJ 
type of double strand break repair pathway called backup pathway (B-NHEJ), which 
is generally utilized when D-NHEJ is compromised, or when there is chemical 
inhibition or mutations in any of the factors participating in the D-NHEJ. This 
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inactivation of D-NHEJ results in the activation of B-NHEJ that removes DSBs from 
the genome by performing a backup function [37]. B-NHEJ is error prone in nature 
[38] and operates with 20-30 fold slower kinetics in comparison to D-NHEJ, which 
repairs nearly half of the DSBs in the first few minutes after irradiation [39-41]. 
Current knowledge about B-NHEJ implicates DNA Ligase III/XRCC1 and PARP1 as 
the core components of this process along with the Histone H1[42].  
The second part of the present thesis focuses on some aspects of Histone H1 as a 
stimulatory factor of B-NHEJ.  
Recent data provide evidence for the cooperation of mammalian Mre11 and PARP-1 
in this alternative pathway of NHEJ [43].  Our group reported that higher activity of B-
NHEJ could be observed in the G2 phase of the cell cycle and that becomes 
apparent when measuring DSB rejoining activity in D-NHEJ deficient cells by pulse-
field gel electrophoresis. The results of these experiments indicate that although the 
fast component of NHEJ is compromised at later time points after irradiation, residual 
rejoining activity fully restores genome integrity independently of HRR [44]. We also 
reported that B-NHEJ gets suppressed when Ku binds to DNA ends, particularly 
when it interacts with DNA-PKcs. 
  
1.4.  NHEJ - Still an unsolved puzzle? 
1.4.1.  Ku heterodimer and MRN complex: Initial players in NHEJ 
The Ku70/80 heterodimer is among the first components of the classical NHEJ 
pathway to bind the broken DNA ends of a DSB [7]. It further recruits the 465-kDa 
DNA-PKcs to the DSB resulting in stimulation of DNA-PKcs kinase activity [45-47]. A 
consequence of this mode of end recognition is that Ku and DNA will become 
topologically linked on completion of the repair [48, 49]. Evidently, the Ku 
heterodimer becomes trapped on DNA after completion of the repair event, which 
raises an important question concerning the mechanism of unloading of the trapped 
Ku protein, as well as the possible functional importance of its presence at the site of 
the rejoined DSB. Several theories were proposed in this regard. It is thought that the 
unloading of the trapped Ku heterodimer from DNA might be achieved if the subunits 
could dissociate and thereby compromise the stability of the interface between α/β 
and β-barrel domains within a single subunit, involving some local unfolding of the β-
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barrel [49] (Figure 5). Another theory proposed that there is an ubiquitin-dependent 
removal and degradation of Ku80 from DNA, which is independent of the completion 
of NHEJ. Binding of Ku to DNA induces a signal recognized by an E3 ubiquitin ligase, 
which then polyubiquitylates Ku80. Polyubiquitylation leads to either a conformational 
change in Ku, which releases it from DNA, or, more likely to the recruitment of an 
additional factor that actively dissociates Ku80 from the DNA. After dissociation, 
Ku80 is recognized and degraded by the proteasome [50]. 
Genetic and biochemical evidence have determined that the DNA Ligase 
IV/XRCC4/XLF complex is responsible for rejoining the DNA ends during NHEJ [47]. 
The Ku complex and MRN are known to interact to each other but the mode of their 
interaction and its functional significance remain unknown. In this regard, studies 
show that association of the Ku heterodimer with broken DNA ends inhibits 
recombination in MRX mutants but not in repair-proficient cells or other DNA repair 
single mutant [51].  
One of the most intriguing questions in the field of DSB repair is how and when does 
a cell decide to opt for which pathway to repair a DSB. One of the recent studies 
demonstrate that Ku (70 and 80) is a critical regulator of pathway choice in human 
somatic cells, as Ku can inhibit HR at telomeres and it can inhibit HR and B-NHEJ 
throughout the genome [52]. There are findings which provide strong evidence that 
the different DNA DSB binding properties of Mre11 and Ku determine the different 
efficiencies of HRR and NHEJ to repair high LET induced radiation [53].  
Although the Ku heterodimer and the MRN complex are the earliest molecules to be 
recruited to the sites of DSBs [54] and are known to interact with each other [55], the 
functional relevance of this interaction is not known. It is therefore particularly 
relevant to study the possible implications of this interaction on DNA damage repair 
and to determine whether induction of damage leads to positive or negative 
regulation of this interaction. It is possible that the nuclease activity of Mre11 has a 
role to play in the unloading of trapped Ku from the repaired DNA ends, but the 
contribution (like post translational modifications of Ku) of other MRN complex 
partners cannot be ruled out. For studying these aspects of the interaction, in depth 
knowledge of the structure of the Ku heterodimer and MRN proteins is important. 
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1.4.2.  Biochemistry and structure of Ku heterodimer 
The sequence similarity between the two Ku subunits over their entire length 
suggests that they originated from a common ancestor [7, 56, 57]. Each Ku subunit 
consists of three regions: an amino-terminal von Williebrand A domain (vWA), a 
central core domain and a diverged carboxy-terminal region (Figure 4). vWA domain 
is responsible for protein-protein interactions and is involved in the 
heterodimerization of Ku [7]. The carboxyl-terminal region of Ku70 consists of a SAP 
domain, thought to be a DNA binding domain which helps Ku translocation on linear 
DNA molecules [49] and ensures the ability of Ku70 to bind weakly to DNA in the 
absence of Ku80 [7]. The carboxy terminal domain of Ku80 is longer and contains the 
binding region of the DNA-dependent protein kinase catalytic subunit.  
 
 
 
 
 
 
 
 
 
 
Figure 4: Structure of Ku heterodimer: Domain boundaries, phosphorylation sites (red, 
protein-protein interaction sites and interacting proteins (yellow ovals) are shown for (A) 
Ku70 and (B) Ku80. Domain boundaries for the Von Williebrand domain (vWa) (amino acids 
35-249). Ku core (amino acids 266-529) and SAP domains (amino acids 573-607) of Ku70 
and the vWa (amino acids 7-237), Ku core (amino acids 244-543) and C-terminal domains 
(amino acids 590-709) of Ku80. The location of putative nuclear localization sequences 
(NLS) in Ku70 (amino acids 539-556) and Ku80 (amino acids 561-569) are indicated [58].  
 
1.4.3.  The fate of Ku trapped on DNA 
The Ku heterodimer is a structure specific, sequence independent DNA binding 
protein [7]. Ku has extreme DNA affinity and can bind to the ends of DNA, for 
example- 3’-5’ overhangs of double stranded oligonucleotides, blunt ends and other 
Introduction 
 - 9 -
 
nucleotidic structures like nicks, gaps and bubbles in circular dsDNA, single stranded 
DNA and RNA [48, 59, 60]. The Kd values for DNA-end binding by Ku are in the 
range of 2.4x 10-9 - 5x10-10 M-1. Ku is known not to require ATP for DNA binding and 
once bound to double stranded DNA and it can translocate along the molecule in an 
ATP independent way allowing multiple subunits of Ku to bind to linear DNA, at least 
in vitro [61]. The crystal structure of Ku bound to DNA revealed that the complex has 
a open-ring like shape with the DNA threaded through the aperture [49, 62]. Ku ring 
is designed with a base that cradles DNA, and a very narrow bridge (strand β) on 
each subunit that acts as a barrier to promiscuous binding to unbroken DNA [49] 
(Figure 5). It has been observed that Ku protein binds to the ends of DNA and then 
slides along DNA to offer free ends for the next Ku protein binding [7]. Therefore, the 
Ku protein binds DNA by adding molecules at two ends of DNA until the fragment is 
completely covered with protein molecules (accumulative binding) [63-65]. Ku80 
requires Ku70 for binding to DNA, Ku70 has weak DNA binding activity on its own 
[66]. Ku binds to linear DNA much more efficiently than to closed super coiled DNA 
[61]. No major structural changes have been observed to the ring itself that is needed 
to thread a DNA end through the complex. 
 
1.5.  The biological machine: MRN Complex 
The MRN complex, comprising Mre11, Rad50 and Nbs1, is a highly conserved 
protein complex, which is among the earliest molecules that sense DNA damage 
[67]. The reported Mre11 and Ku heterodimer interaction is in agreement with the 
roles proposed for these proteins in NHEJ as they are the earliest players to take a 
lead in the choice of the DSB repair pathway [28, 68, 69]. MRN complex is now 
considered to be a bridging factor or the junction between the different repair 
pathways available to a cell (D-NHEJ, HRR, and B-NHEJ), as probably the 
complexity of the DSB or the type of DNA ends generated after DNA damage 
induction allows MRN complex to make a pathway choice. This complex is a principal 
component of signalling pathways involved in cellular responses to DNA DSBs. All 
three complex subunits have analogues from yeast to mammals [70, 71]. The MRN 
components have different enzymatic activities, thus making MRN complex a sensor 
of DNA damage, a DNA end processing molecule and a signal transducer involved in 
DNA damage response signalling. The MRN complex also participates in DNA 
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replication, meiotic recombination, mitosis and telomere maintenance [72-74]. The 
importance of this complex can be gauged by the fact that null mutations in any of its 
components (Mre11/Nbs1/Rad50) results in embryonic lethality in mice [75]. 
Individuals inflicted with mutations in any of the MRN subunits suffer inherited cancer 
prone diseases such as NBS (Nijmegen breakage syndrome) and ATLD (Ataxia 
Telangiectasia like disorders) [76]. These autosomal disorders are marked with 
radiosensitivity and defective cell cycle checkpoints. Cells with deficiencies in MRN 
components are very similar to those of ATM-deficient cells with respect to the IR-
induced cell-cycle arrest [77] resulting in a dramatic reduction of targeted integration 
frequencies, gene conversion and sister chromatid exchanges, and impaired single 
strand annealing [78]. 
The complex containing Mre11, Rad50 and Nbs1 proteins have now been implicated 
in all three major DNA repair pathways – HRR, D-NHEJ and B-NHEJ, even though 
these pathways are quite different mechanistically [79, 80]. The MRX complex in 
yeast plays an important role in homologous recombination, non-homologous end 
joining, telomere maintenance, S-phase checkpoint control and meiotic 
recombination [54]. 
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Figure 5: (A) Crystal structure of Ku heterodimer: View down of the DNA helix, Ku70 is 
coloured red and Ku80 orange. Only the 14bp duplex DNA is shown. The sugar phosphate 
backbone is coloured light grey and bases dark grey [49]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: (B) Ribbon diagram of Ku bound to DNA: Ku70 is coloured red and Ku80 
orange. The 34-residue oligonucleotide is light grey, the 21 residue oligonucleotides dark 
grey [49].  
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1.5.1.  Biochemistry and structure of the MRN complex  
1.5.1.1.  Mre11 
The human Mre11 is composed of 708 amino acids (a.a) and consists of four 
conserved phosphoesterase domains at the N-terminal and two DNA binding 
domains at the C-terminal (Figure 6). The N-terminus has an Nbs-1 binding site and 
the C-terminus contains a Rad50 binding site. The Phosphoesterase, or nuclease, 
domain is responsible for several biochemical properties of the protein such as the 
3’-5’ double stranded DNA exonuclease (which are Mn2+, ATP and Nbs1 dependent), 
single stranded DNA endonuclease and DNA unwinding activities [81]. The nuclease 
activity of Mre11 is structure specific, the double stranded DNA exonuclease function 
of the protein is active on substrates with blunt or 3’ recessed ends, but is poorly 
active on 3’ protruding ends [79, 82, 83]. The endonuclease activity of Mre11 is also 
weakly active on hairpin DNA substrates and is stimulated by ATP [84]. It has been 
reported that the nuclease activity of Mre11 is only required for the purpose of DNA 
repair and not for DSB signalling and telomere maintenance, a point that is 
ambiguous when referring to budding yeast studies [85]. Mre11 has an intrinsic DNA-
binding activity [81, 83] carried out by the DNA binding domain, which is stimulated 
by Rad50 on its own or in combination with Nbs1. The N-terminal part of Mre11 
interacts with C-terminus of Ku70 and this interaction was confirmed in a yeast two-
hybrid system [55]. 
Mre11 is known to dimerize and to form a homodimer, which is needed for the basic 
MRN functions and which is also required for Mre11 DNA binding in vitro, and Mre11 
repair activity in vivo [86]. Scanning atomic force microscopy revealed that the MRN 
complex has a bipolar architecture in which human Mre11 and Rad50 bind DNA via a 
globular domain consisting of an Mre11 dimer and two Rad50 ATPase domains, 
while the coiled coil regions of Rad50 form an extended intra-molecular flexible arm. 
Thus, interactions between the coiled-coils of DNA bound Mre11 complexes would 
tether sister chromatids or DNA ends within the same chromatid [87, 88]. 
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Figure 6: Domain structure of Mre11: Mre11 has an N-terminal phosphoesterase or 
nuclease domain, and a C-terminal DNA binding domain. The Mre11 catalytic domain 
(residues 1-342) bind to Mn2+ and the exonuclease product of Mre11, when 3’-5’ 
exonuclease activity is catalysed [89]. 
1.5.1.2.  Rad50 
Rad50 is a 150 KDa ATP-dependent protein belonging to the “structural maintenance 
of chromosomes’’ SMC group of proteins consisting of 1328 amino acids and 
containing Walker A and Walker B nucleotide (NTP)-binding motifs that confer 
ATPase activity [90] at its amino and carboxy-terminal ends (Figure 7). These motifs 
are separated by two heptad-repeat regions, which form an extended coiled-coil 
structure that is interrupted by a putative globular domain [79, 90]. Rad50 forms an 
anti-parallel homodimer that brings together the Walker A and B binding motifs of 
separate Rad50 molecules to create a functional ATP binding domain. Mre11 seems 
to bind as a dimer on the extremity of the coiled-coil region that is proximal to the 
catalytic domain of Rad50. The ATP binding motifs are crucial for all known activities 
of MRN including ATM activation. The proposed main function of Rad50 is to bind 
damaged DNA ends and hold them in close proximity. 
Rad50 (150 kDa) 
 
 
 
Figure 7: Domain structure of Rad50: Rad50 has ATP binding cassettes (ABC), ATPase 
and central Zn-hook domains. ATPase-N and ATPase-C terminal domains are separated by 
600 amino acids anti-parallel coiled coil. The central Rad50 region bears a CxxC motif that 
reverses directionality of the coiled coil and co-ordinates Zn2+ to mediate hook-hook 
interactions [89]. 
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1.5.1.3.  Nbs1 
The third subunit of eukaryotic MRN complex, Nbs1 (or its functional homolog Xrs2 in 
Saccharomyces cerevisiae) is much less sequence conserved and only found in 
eukaryotes [22, 91, 92]. Nbs1 is a 90 kDa protein consisting of 754 amino acids and 
shows three functional regions: A Fork Headed-associated Domain (FHA) at C-
terminus (24-108 a.a.), which is believed to be a phospho-specific protein-protein 
interaction motif that recognises phosphorylation of target proteins (Figure 8). FHA 
domain directly interacts with the histone γ-H2AX, the phosphorylated form of H2AX, 
and leading to the recruitment of the MRN complex to the vicinity of DSBs. A central 
region, which also functions in signal transduction, consists of the BRCT domain 
(108-196 and 221-330 a.a.) and ATM phosphorylation sites at serine residues 278, 
343 and 615, which is responsible for the intra S-phase checkpoint control [54]. The 
C-terminal region of Nbs1 is responsible for the interaction with Mre11 and ATM. 
Nbs1 regulates the Mre11 and Rad50 catalytic activity by forming a complex with 
them and localises Mre11 and Rad50 to the nucleus and interacts with other DNA 
repair proteins, for example ATM, γ-H2AX and MDC1. 
Nbs1 (90 kDa) 
 
 
 
 
 
Figure 8: Domain structure of Nbs1: Nbs1 consists of an N-terminal Fork head-associated 
(FHA) domain. There are two important phosphorylation sites, Ser278 and Ser343 for 
phosphorylation by ATM. The structure also includes the Mre11-binding motif and the BRCT 
phosphor-peptide interaction domain [89].  
 
1.6.  How does MRN complex respond to DNA damage? 
Mre11 is homogenously distributed within the nucleus in undamaged cells but 
migrates rapidly to the sites of DNA double strand breaks, showing association with 
damaged DNA within 10 min post irradiation in the form of small granular foci [22]. 
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Initial recruitment is probably via its DNA end binding activity, but subsequently, 
excess MRN is recruited to the vicinity of DSBs in large focal structures regulated by 
its interaction with γ-H2AX. The MRN complex is thought to bind and secure the DNA 
ends together via its zinc hooks at the ends of the long flexible Rad50 arms, with the 
Mre11 molecules binding to DSBs. Upon DSB binding, the Rad50 arms undergo 
structural modifications, becoming rigid and parallel and bridging both DNA ends 
using the zinc hook. Secured in this fashion, the initial step of DSB processing is 
thought to take place. 
In addition, the signalling cascade of DNA damage response (DDR) is activated with 
the initial steps being activation of ATM kinase. Inactive ATM kinase is a dimmer, 
which after monomerization is believed to be recruited to DSBs by Nbs1, resulting in 
autophosphorylation and activation of ATM kinase activity. Further, ATM kinase 
phosphorylates many DNA-damage response proteins including Nbs1 itself [54]. 
CtIP, which is an end processing nuclease, is also phosphorylated by ATM and 
interacts with MRN [93]. Many other DNA damage response proteins are also 
recruited to the sites of DNA damage and contribute to DSB processing and repair. 
PARP-1, which is not directly linked to checkpoint activation, is rapidly activated by 
DNA strand breaks (both single and double strand breaks) and signals the presence 
of DNA lesions by attaching ADP-ribose units to chromatin associated proteins. 
There is evidence [94] that Mre11 can directly bind to these ADP-ribose units via 
short poly ADP-ribose (PAR) binding motif localized between the two DNA-binding 
regions. Recent findings implicate Mre11 in backup pathways, as rapid accumulation 
of Mre11 and Nbs1 at the sites of DNA damage requires PARP-1, thus hinting 
towards a bridging role for MRN complex between D-NHEJ and B-NHEJ. 
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1.7.  MRN complex - Role in DNA repair pathways 
 
 
 
 
 
 
 
 
 
Figure 9: MRN is a key player in DDR: MRN operates in early cellular responses to DNA 
processing, for example in HRR, NHEJ, in meiotic recombination, telomere maintenance and 
ATM activation (Courtesy Hopfner lab, LMU, Munich, Germany). 
 
1.7.1.  MRN in HRR 
HRR is facilitated by recognition of the DSB by CtIP (endonuclease activity) which 
gets phosphorylated by ATM and mediates the processing of DNA ends. CtIP has 
the ability to bind and promote Mre11-directed nuclease processing in the 5’-3’ 
direction to yield 600-800 nucleotides of 3’ single stranded DNA [95, 96]. These 3’ 
single stranded tails are then coated and protected by RPA (replication protein factor 
A) [97]. With the help of Rad52 epistasis group members [98]: Rad52, the RAD55/57 
heterodimer, Rad54 and in higher eukaryotes the breast cancer susceptibility protein 
BRCA2, the DNA strand exchange protein Rad51 displaces RPA generating a 
nucleoprotein filament that invades homologous DNA segments for polymerase mediated 
extension [33]. The HRR process is completed after strand resolution (resolution of Holliday 
junction) and ligation of the generated DNA ends. Mre11, Rad50, and XRS2 have been 
suggested as candidates for the nuclease that resects 5’ ends in meiosis prior to 
homologous strand exchange in yeast [99]. 
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1.7.2.  MRN in NHEJ 
It is commonly believed that the predominant pathway for DSB repair in 
mammalian cells is D-NHEJ. Although the nuclease activity of Mre11 is not important 
for accurate NHEJ, its involvement has been reported in the budding yeast [28, 69, 
100-104]. Inaccurate repair has been reported in plasmid end-joining assays in the 
absence of Ku heterodimer on the top of Mre11 activity loss. Interaction of 
mammalian Ku70, which is paramount component for D-NHEJ, with Mre11 has been 
reported, which raises the possibility that Ku70 recruits Mre11 to the sites of DSBs. 
Also cells deficient in Ku70 were deficient in Mre11 foci formation after exposure to 
IR [55]. Furthermore, in hamster cells, co- localization of Ku protein with Mre11 has 
been reported and physical interactions between mouse Mre11 and Ku documented 
[105].  
On the other hand, genetic studies suggest that in yeast Mre11 and Ku 
function in distinct repair pathways [106, 107]. It has also been reported that 
dissociation of NHEJ proteins from repaired damage sites depends on MRX and ATP 
binding by Rad50, indicating that the MRX complex may be the critical factor in repair 
pathway switching, at least at the ends that failed NHEJ [108]. The most obvious 
mechanism for this dissociation would be MRX-stimulated resection of DSB ends for 
HR, which seems incompitable with continued NHEJ protein binding protein. [108]. 
Loss of Ku leads to more rapid resection at the ends of the DSBs [109, 110] and 
increases HRR efficiency, indicating that removal of Ku from DNA is necessary to 
initiate HRR. Since both proteins are present in a wild type cells, the cells must 
engage appropriate mechanisms to ensure the proper coordination in the function 
between the different proteins involved in the processing by the different repair 
pathways.  
Whether Mre11 plays a role in unloading of Ku from repaired/rejoined DNA is 
still not clear. Also, it is not clear whether Ku assists the recruitment of Mre11 on the 
DSB sites. Mre11 seems to have a bridging function for homologous stretches of 
DNA and/or broken DNA ends [111]. The core of Mre11-Rad50 complex exists as a 
heterotetrameric assembly (M2R2)2 and for non-homologous end- joining, a Zn2+-
linked (M2R2)2 octamer may be responsible for bringing the two ends together. 
Alternatively, two broken ends might bind to the head of the same Mre11 complex 
that has inserted Zn2+ linkage [112]. The specific role of Mre11 in classical NHEJ is 
not clear as the MRN complex takes part in several processes of DNA repair 
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including D-NHEJ and B-NHEJ. However, it is very difficult to rationalize how MRN 
will be able to dominate over Ku once a DSB is induced. The models tested in the 
present thesis are first attempts to address this question.  
 
1.7.3.  MRN in B-NHEJ/A-NHEJ 
As we have discussed above, NHEJ can be divided into two sub-pathways, one is 
the classical or canonical DNA-PKcs dependent NHEJ (D-NHEJ) and the other one, 
is a DNA-PK independent backup, or alternative pathway (A/B-NHEJ); the latter is 
also referred to as microhomlogy-mediated end joining (MMEJ) to indicate the higher 
use of microhomologies at the generated junctions. There is evidence that B-NHEJ 
utilizes DNA Ligase III/XRCC1, histone 1 and PARP-1. Recent studies have also 
implicated Mre11 as an important player in B-NHEJ. It has been observed that loss of 
Mre11 affects both D-NHEJ and B-NHEJ and decreases the end- joining frequencies 
in some experimental systems. On the other hand, Mre11 over-expression activates 
the resection of single stranded DNA and increases alternative end-joining. Mre11 
nuclease activity was found to be an essential factor favoring A-NHEJ [43, 113]. 
Another study pointed out the usefulness of alternative pathways in DSB repair in 
mammalian cells and the role of Nbs1, which is vital for alternative NHEJ of hairpin 
coding ends, but suppresses the joining of signal ends in V(D)J recombination 
intermediates [114].  
Evidence accumulates that Mre11 contributes to the regulation of DSB repair 
pathway choice and that it contributes to alternative NHEJ of coding ends in V(D)J 
recombination. However, it is not clear how Mre11 and PARP-1 interact or coordinate 
their functions within B-NHEJ [114]. 
It is known that PARP-1 and Ku compete with each other for DNA ends during DSB 
repair, However, in irradiated cells, the higher affinity of Ku for DNA ends and the 
excessive number other forms of lesions that also recruit PARP-1, limits PARP-1’s 
contribution to DSB repair [115]. As PARP-1 and the MRN complex are important 
candidates of B-NHEJ and may work in conjunction with histone H1, we sought to 
decipher the possible interactions between the MRN complex, PARP-1 and histone 
H1 proteins. The structure and function of PARP-1 protein is described in the 
following passages. 
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1.8.  PARP-1 
PARP-1 is a member of large family of enzymes that use NAD+ as substrate to 
transfer ADP-ribose units onto the glutamic acid residues of proteins. Poly ADP-
ribosylation is a posttranslational modification of nuclear enzymes, which is 
stimulated by SSBs and DSBs and assists somehow in the repair of cells carrying 
this form of damage [116]. It is a DNA repair enzyme and also a chromatin 
associated protein mostly found in the nucleus of eukaryotic cells. 
 
1.8.1.  Structural Organization of PARP-1 
PARP-1 is a monomer of 116 kDa composed of three functional domains (Figure 10). 
The N-terminus has a DNA binding domain which binds to SSBs, DSBs, crossovers, 
cruciform structures and supercoils [117]. The central region contains the auto 
modification domain, which has a BRCT1 at the C-terminal region and which is 
involved in several protein interactions related to DNA repair, recombination and cell 
cycle checkpoint. The catalytic domain contains an NAD+ binding site. An immediate 
cellular response to DNA damage induced by alkylating agents, ionizing radiation or 
oxygen radicals is mediated by the activation of the catalytic domain. The targets of 
PARP-1’s enzymatic activity includes PARP-1 itself, core histones, the linker histones 
and a variety of transcriptional regulatory factors that interact with PARP-1. 
Autoribosylation of PARP-1 is important because this property results in the release 
of PARP-1 from the DNA and initiates the function of other DNA repair proteins.  
 
 
 
 
 
 
 
Figure 10: Domain structure of PARP-1: PARP-1 has a carboxyl terminal domain that 
catalyzes poly(ADP)-ribosylation reactions using NAD+ as donor of ADP-ribose groups. 
PARP-1 also has an amino terminal DNA binding domain (DBD) containing three zinc finger 
motifs, a nuclear localization signal and an auto modification domain. 
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1.9.  Role of PARP-1 in DNA repair 
PARP-1 plays an important role in sensing DNA damage. PARP-1 is a key signaling 
enzyme involved in triggering the repair of single-strand DNA damage [1-3] and also 
in base excision repair [118]. It binds as a homodimer to SSBs through its N terminal 
zinc fingers and recruits XRCC1, DNA Ligase III, histone H1 and DNA polymerase β 
[119]. PARP-1 is also known to play a role in the remodeling of chromatin by 
PARylating histones and relaxing chromatin structure, thus increasing DNA 
accessibility to repair factors. PARP-1 together with DNA Ligase III has also been 
implicated in an alternative or backup pathways of NHEJ [115]. One study also 
observed collaboration between PARP-1, Mre11 and Nbs1 at the proximity of the 
DNA lesion [94]. PARP-1 deficiency is implicated in colon and liver tumorigenesis. 
Deficiency of PARP-1 accelerates ageing and spontaneous carcinogenesis in mice, 
which are hypersensitive to high doses of ionizing radiation and die within 10 days. 
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1.10.  Aims / Objectives of the thesis 
 
General Aim 
The general aim of the thesis is to evaluate and gain deeper understanding of 
the interactions between Mre11 and Ku in cells exposed to IR. 
 
Specific Aims 
(I) 
 To investigate the role of Mre11 as a sensor protein and to determine its 
function in DSB repair in cells exposed to ionizing radiation. Particular 
emphasis was placed on the investigation of interactions between Ku and 
Mre11. 
 To study the effect of different X-ray doses on the interaction between Mre11 
and Ku. 
 To examine the stability of these interactions and to investigate whether these 
interactions are direct or indirect (DNA or oligonucleotide dependent). 
 To monitor the kinetics of recruitment of Mre11 at the sites of DSBs after 
exposure of cells to ionizing radiation. 
 To investigate the regulation of radiation-induced interactions between Mre11 
and Ku. 
 To find potential interacting partners of Ku and Mre11. 
(II) 
The second part of my thesis focuses on the well-known DNA damage sensor 
PARP-1. Here, the following objectives are tested: 
 Examination of the possible interactions between Mre11 and PARP-1 in an 
attempt to bridge the role of Mre11 between D-NHEJ and B-NHEJ. 
 Test the activity of purified PARP-1 in the presence or absence of histone H1 
and analyze this function vis a vis the function of B-NHEJ.  
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2.  Materials and Methods 
2.1.  Materials 
2.1.1.  Laboratory Apparatus 
 
AI Filter           GE-Healthcare, Germany 
AEKTA purifier 10/100 UPC-900       GE Healthcare, Germany 
Avanti J-20XP                                     Beckman Coulter, USA 
Beckman Tabletop GS-6R centrifuge      Beckman, CA, USA 
BioFuge (Fresco)                                          ThermoScientific, USA 
Cell culture Bench                                        Thermo Scientific, Heraeus 
Coulter Counter                                          Beckman Coulter, USA 
Electro-Transfer Unit                                      Bio-Rad, USA 
EMSA gel apparatus                                     Bio-Rad, USA 
Flow Cytometer                                           Beckman Coulter 
Gel Dryer                                                       Bio-Rad, USA 
Heating unit                                                   Peter Oehman, Germany 
Incubator           Sanyo, Japan 
Magnetic Stirrer                                                         Heidolph, Germany 
Microscope                                                                Olympus, Germany 
Molecular Imager VersaDoc                                   Bio-Rad, USA 
Nanodrop                                                                Nanodrop Technologies 
Overnight Culture Shaker         Infors, Germany 
Pasteur pipette         Falcon, USA 
Peristaltic pump         Ismatec 
pH Meter          InoLab, Germany 
Pipettes            Eppendorf, Germany 
Rocky            Peter Oehmen gmbh 
Roller drum           Bellco Biotechnology 
SDS PAGE mini gels         Mini PROTEAN, Bio-Rad 
Typhoon Scanner          GE Healthcare, Germany 
Ultracentrifuge         Beckman Coulter, USA 
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UV Spectrophotometer        UV-240IPC, Shimadzu 
Vortexer(Vortex-Genie 2)        Scientific Industries, USA 
Water Bath           Oehmen Laboratory 
Weighing Machine         Sartorius (BP110 S) 
X-ray machine (320KV)         GE Healthcare, Germany 
Gel blotting Paper          Bio-Rad, USA 
2.1.2.  Disposable Elements 
0.2 μm filter          Millipore, USA 
1.5 and 2 ml tubes         Eppendorf, Germany 
15 & 50 ml Centrifuge Tubes       Falcon,USA 
Cell Culture Dishes         Cellstar, USA 
Dounce homogenizer        KonTes, Kimble Chase LLC 
Flasks and beakers         Simax, Germany 
Gel blotting Paper         Bio-Rad, USA 
Mouse or Rabbit True blot IgG Agarose beads     e-Biosciences, USA 
Nitrocellulose membrane        Schleicher & Schuell 
Pipettes          Rainin, USA 
PVDF membrane         GE Healthcare, Germany 
Spinner Flask         Bellco, USA 
UV Cuvettes          Hellma, USA 
Parafilm          Lab Depot Inc. USA 
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2.1.3.  Chemical Reagents 
The chemicals used were of analytical grade 
Acrylamide-Bis-acrylamide (37:5.1)      Roth, Germany 
Albumin Bovine         Sigma-Aldrich, Germany 
Bromophenol Blue         Sigma-Aldrich, Germany 
DMEM          Sigma-Aldrich, Germany 
DTT           Roth, Germany 
EDTA           Roth, Germany 
Ethanol          Roth, Germany 
FCS/FBS          Gibco, Germany 
Glycerol          Roth, Germany    
Glycine          Roth, Germany 
Grace’s Insect Medium        Gibco Life Sciences 
Isoproponal          Roth, Germany 
KCl           Roth, Germany 
Lactalbumin hydrolysate        Sigma-Aldrich, Germany 
McCoy’s5A          Sigma-Aldrich, Germany 
MEM           Gibco, Invitrogen 
Methanol          Sigma-Aldrich, Germany 
NaCl           Roth, Germany 
Non-Fat dry milk         Roth, Germany 
Nonidet P40          Roche, Germany 
Propidium Iodide         Sigma-Aldrich, Germany 
RNase          Sigma-Aldrich, Germany 
TEMED          Roth, Germany  
TRIS Base          Roth, Germany 
Tris-HCL          Sigma-Aldrich, Germany 
Triton X-100          Roth, Germany 
Trypsin          Biochrome, Germany 
Coomassie brilliant blue G250       Serva, NewYork 
Tween 20          Roth, Germany 
Yeastolate ultrafiltrate        Gibco, Germany 
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2.1.4.  Commercial Kits and Columns 
γ-32P           Perkin Elmer, USA 
DNA cellulose resins        Sigma-Aldrich, Germany 
ECL Western Blotting Reagent       GE Healthcare, Germany 
Hi Load (26/60) Superdex 200       GE Healthcare, Germany 
HITrapTMHeparin prepacked column      Amersham Biosciences 
QIAquick Nucleotide removal Kit       Qiagen, Germany 
Sephadex 200         GE Healthcare, Germany 
Super signal West Femto sensitive kit      Thermo Scientific, Germany 
T4 polynucleotide Kinase        Fermantas, 10U/µl, Germany 
T4 polynucleotide Kinase Forward buffer     Fermantas, Germany 
 
2.1.5.  Cell lines 
Table 2.1: Cell lines used in cell culture experiments. 
 
Name         Description Culture Medium Refrences 
HCT116 Colorectal Carcinoma McCoy's 10% FBS [120] 
A549 Human alveolar basal 
epithelial cell carcinoma 
 
McCoy's 10% FBS 
[121] 
Xrs6 Chinese hamster ovary cell 
mutant deficient in Ku80  
MEM + 10% FCS [122] 
M059 J 
and K 
Human Glioma cell lines. 
M059J is DNA-PKcs mutant  
DMEM+10% FCS6 [123] 
AT5BIVA Immortalized Ataxia 
Telangiectasia cells 
McCoy’s 5A + 10% 
FCS (20mM Hepes 
pH 6.85) 
[124] 
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2.1.6.  Oligonucleotide Sequences 
Table 2.2: Oligonucleotides used in experiment. 
 
Name of Oligos Sequence(5’-3’) 
 
Oligonucleotides 
(EMSA) 
 
    OA-(GGC CGC ACG CGT CCA CCA TGG GGT ACA A) 
    OB-( TTC TAC CCC ATG GTG GAC GCG TGC GGC C) 
 
Note: Annealing of the oligonucleotides OA with OB results in blunt end double 
stranded DNA. This DNA was 3’ end labeled using γ-P32 ATP with polynucleotide 
kinase for EMSA. 
 
2.1.7.  Antibodies 
Table2.3: Antibodies used in Western Blotting analysis. 
Antibodies MW(kDa) Type Manufacture Cat. number Dilution 
 
Primary Ab      
 
Ku70-N3H10 70 mAb Kamiya Biomed MC-351 1:1000 
Mre11 81 pAb Novus B100-142 1:5000 
Nbs1 95 pAb Novus NB100-143 1:5000 
Rad5013B3 160 mAb GeneTex GTX70228 1:1000 
ATM-2C1 236 mAb GeneTex MS-ATM-10pX1 1:1000 
GAPDH 30 mAb Chemicon MAB374 1:100000 
PARP-C-2-10 116 mAb Sigma-Aldrich P-248 1:1000 
 
Secondary Ab      
Mouse IgG-HRP  mAb Cell Signalling 7076 1:1000 
Rabbit IgG-HRP  pAb Cell Signalling 7074 1:1000 
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2.1.8.  Software Used 
Table 2.4: Software used for quantification of results. 
 
 
2.2.  Methods 
2.2.1.  Cell Culture 
Tissue culture was performed in incubators at 37°C with 5% CO2. A549 Cells were 
maintained in McCoy’s 5A medium, M059K and M059J cells were a kind gift from Dr. 
J. Allalunis-Turner (Cross Cancer Center, Edmonton, Canada) and were maintained 
in DMEM. HCT116 DNA-PKcs-/- and DNA-PKcs+/+ wild-type (wt) cells ( a gift of Prof. 
Dr. Eric Hendrickson) were maintained in McCoy’s 5A medium and AT5BIVA cells 
were maintained in MEM medium. Insect Sf9 cells (suspension cells) were grown in 
spinner cultures at 27°C in Grace’s insect medium.  
All adherent cells were grown in 100 ml tissue culture dishes with 15 ml growth 
medium. Exponentially growing cells were passaged every 3 days while avoiding 
confluency levels above 80%. For passage, media was removed and cells were 
rinsed with 1x ice cold PBS. Cells were rinsed with 2 ml Trypsin-EDTA solution and 
incubated for 5 min at 37°C. Detached cells were then resuspended in 10 ml cold 
media supplemented with 10% FBS. Single cell suspensions were obtained by 
passing cells through a Pasteur pipette. Cells were counted and appropriate number 
of cells was further incubated for experiments or for subculture, see Appendix (1). 
Cells were discarded after about 50 passages, since their genomic stability could not 
be guaranteed. 
                  Program         Software     
                 Image Quant          Molecular Dynamics (Invitrogen) 
                 Quantity One         Biorad 
                 Illustrator         Adobe 
                 Sigma plot         Systat  
                 MS Office         Adobe 
                 Unicorn         Aekta 
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2.2.2.  Ionizing radiation (IR) 
Cells were exposed to X-rays generated at 320KV, 10mA after a 1.65 Al filter. 
Dosimetry was performed with PTW and or chemical dosimeter, which were used to 
calibrate an in-field ionization monitor. The doses mostly used were 2, 4 and 8 Gy. 
An even distribution of dose of radiation dose on the cell cultures was ensured by 
rotating the radiation table. Cells were returned to the incubator immediately after 
treatment with IR and collected at different times, from 10 min to 8 h depending on 
the experiment. 
 
2.2.3.  Flow cytometry 
2.2.3.1.  Cell cycle analysis by flow cytometry 
Propidium iodide binds to DNA proportionally to its mass. Cells cycle distribution was 
assessed by measuring propidium iodide (PI) fluorescence in a flow cytometer. Cells 
were washed with cold PBS and trypsinized at 37°C for 5 min. Cell suspensions were 
prepared in 5 ml cold fresh media. About 1 million cells were collected and 
centrifuged at 1500 RPM, 4°C for 5 min. The cell pellets were washed with 1x ice 
cold PBS and fixed in 70% ethanol at -20°C overnight. Supernatant was removed by 
centrifugation at 1500 RPM for 5 min. Pellets were washed with 1x ice cold PBS and 
incubated in 1x PBS containing PI (40ug/ml), and RNase (62µg/ml) at 37°C for 30 
min in the dark. Samples were measured in a flow cytometer according to pre-
established protocols, see Appendix (1). 20,000 cells per sample were counted and 
the single cell population was gated to obtain standard histograms. Histogram list 
mode files (*.HST) were generated by counting the frequency cells with same PI 
signal intensity. The fractions of cells in the different phases of the cell cycle were 
calculated using the Wincycle® software. HST files were loaded into the Wincycle®. 
The parameter “S phase growing cells order” was carefully chosen between 0, 1 or 2, 
until the prediction model fitted the histogram shape. Cell cycle distributions were 
automatically calculated. G2 arrest kinetics was obtained by plotting the G2 fraction 
as a function of time after IR.  
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2.2.4.  Electrophoresis 
2.2.4.1.  SDS-PAGE 
Cell lysates and immunoprecipitation reactions were electrophoresed on 10 % SDS-
PAGE gels. Cell lysates were denatured with 2X SSB and heated on 95°C for 5‘ and 
centrifuged for 5 min on 13000 rpm before loading. SDS-PAGE mini gels were cast 
according to the instructions given by the manufacturer of the apparatus. Samples 
were resolved for 20 min on 100V from the stacking gel and the voltage was then 
adjusted to 150V for a 60 min run on RT so that samples fractionate throughout the 
resolving gel. For further details refer to Appendix (2). 
2.2.4.2.  Western Immunoblots 
Cell lysates and immunoprecipitates were resolved on 10% polyacrylamide gels and 
transferred on a PVDF membrane. PVDF membranes were activated by rinsing them 
for 1 minute in 100% methanol and then washing them thrice with MQ water briefly. 
Activated PVDF membrane and gels were incubated in 1X cold transfer buffer 
(Glycine 200mM, Tris 25mM, 10% methanol) at 4°C for 15-20 minutes on a rotator. 
Meanwhile the sponge and blotting paper were pre-soaked into transfer buffer and 
then all components were assembled into the electro-transfer unit according to the 
instructions of the manufacturer and run at 100V for 60 min. After the transfer was 
completed, the unit was disassembled and the side of membrane on which proteins 
was transferred was incubated in blocking buffer (5% non-fat dry milk dissolved into 
1X TBST for 2 h at RT with gentle agitation. Membranes were incubated with primary 
Ab for overnight at 4°C. After incubating membranes into primary antibodies the 
membranes were washed gently with 1X TBST (5x 5min) and then probed with 
secondary antibody, linked with horseradish peroxidase, for 1 h. After incubating 
membranes in secondary antibodies the membrane was washed again with 1XTBST 
(5X 5min). For more details, refer to Appendix (2). 
2.2.4.3.  Western Blot detection 
Western blots were developed using the ECL developing solution which is a 
chemiluminescence detection kit; solution A and solution B were mixed together in 
ratio 1000:25 µl, spread on membrane, incubated for 5 min and visualised using 
molecular imager VersaDoc MP 4000 System. Quantification of protein amounts was 
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performed using the ImageQuant software and Quantity one. For some blots which 
had weak signals, Super Signal West Femto Maximum sensitive Kit was also utilized 
for developing Western blots, in which solution A and B were mixed in 1:1 ratio. 
2.2.4.4.  Antibodies 
The primary antibodies and secondary antibodies are given in Table 2.2 in the 
“Materials” section. 
2.2.5.  Cell Fractionation 
2.2.5.1.  Preparation of whole cell extract 
Whole cell extract was prepared using the freeze-thaw method. First, adherent cells 
were washed once with 1x ice cold PBS and then the pellet was washed once with 
hypotonic buffer, Appendix (4); cells were centrifuged at 1500 rpm for 5 min and the 
pellet resuspended in three PCV hypotonic buffer. The cells were disrupted by 
freezing in liquid nitrogen (3x) and immediately thawing at 37°C. Then 3M KCl was 
added to a final concentration of 500 mM and the mix was incubated at 4°C for 30-60 
min on a rotating platform. Samples were centrifuged at 14000 rpm at 4°C for 40 min. 
and the supernatant was dialysed against 400 mM KCl containing dialysis buffer. 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Flow chart of whole cell extract preparation 
Briefly washed once with 5 PCV Hypotonic buffer
Adherent cells (Trypsinized, collected, cetrifuged 2500rpm,7’,4°C)
Centrifuged at 1500 rpm,5’,4°C
Resuspended pellet in 3 PCV of Hypotonic buffer 
Cell lysis by 3X Freezing in Liquid N2
Immediately thawed at 37°C
Added 3 M KCl to final concentration of 500mM
Incubated the mix (4°C,30 min-1h)
Centrifuged sample at 1400 rpm,45’, 4°C 
Dialysed the supernatent against dialysis buffer
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2.2.5.2.  Cell Fractionation 
(Cytoplasmic extract, nuclear extract and nuclear-bound-protein extract) 
A549 cells were trypsinized, collected, centrifuged at 2500 rpm for 7 min and 
resuspended in 1 PCV of hypotonic buffer. Cells were disrupted by homogenizing in 
Dounce homogenizer (15-20 strokes with a B Pestle) and centrifuged at 3300 rpm for 
30 min. The supernatant containing the cytoplasmic extract was collected , the pellet 
was resuspended into two PCV of low salt buffer (LSB), Appendix (4) and one PCV 
of high salt buffer (HSB)  Appendix (4), and incubated for 30 min under mild rotation 
at 4°C. Samples were then centrifuged at 1300 rpm for 45 min and the supernatant 
was designated nuclear extract and collected in a new tube. The remaining pellet 
was processed in the same manner to obtain the nuclear-bound-protein extract. All 
extracts were dialysed against dialysis buffer, Appendix (4), and centrifuged for 20 
min at 13000 rpm. Protein concentration was determined using the Bradford assay 
and BSA as a protein standard. For more information about buffers refer to Appendix 
(4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Flow chart of biochemical cell fractionation 
Adherent cells, trypsinized, collected, cetrifuged 2500rpm,7’,4°C
Briefly washed once with 5 PCV Hypotonic buffer
Centrifuged at 2500 rpm,5’,4°C
Resuspended pellet in 1 PCV of Hypotonic buffer 
Cell lysis by homogenization through Dounce homogenizer(20 strokes by a pestle)
Centrifuged at 3300 rpm for 30’, 4°C
Cytoplasmic protein
Pellet was resuspended in 2PCV of LSB +1PCV of HSB
Incubated the mix, mild rotation, 4°C,30 min
Sample centrifuged at 1300 rpm,45’, 4°C 
Repeat last three steps to achieve 1st round- CE
2nd round-NE
3rd round-NP
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2.2.6.  Immunoprecipitation 
For Immunoprecipitation reactions, we utilized mouse and rabbit TrueBlot IgG 
agarose beads. Immunoprecipitation was performed initially by pre-clearing of the 
beads with excessive protein and incubating the extract with 50 µl beads/reaction for 
30 min on ice. Then samples were centrifuged at 9500 rpm for 1 min and the 
supernatant collected in a new eppendorf tube. Next, Ku monoclonal antibody was 
added at 2 µg per reaction and incubated on a rotator shaker for 2 h. Subsequently, 
fresh agarose beads (50 µl) were added to each tube and incubated again for 2 h 
under constant rotation. Non-specific proteins were removed by washing beads (3x) 
with 500 µl of IP lysis buffer while centrifuging each wash at 9500 rpm for 1 min. 
Bound proteins were denatured by adding60-100 µl Laemmli buffer to each tube, 
heated at 95°C and run on 10% SDS polyacrylamide gel, before blotting onto a 
PVDF/nitrocellulose membrane. For more information refer to Appendix (3).  
 
 
 
 
 
 
 
 
 
Figure13: Diagrammatic representation of the IP procedure and flow chart of the steps from 
irradiation to fractionation. 
Incubation (37°C)
Trypsinization
Collection
Collection of cells
Centrifuge at 2500 rpm,7min,4°C
Wash 1XPBS(cold)
Centrifuge at 2500 rpm,7min,4°C
Proceed for cell fractionation
CELLS
IR (x-rays)
IP
 Washing beads thrice with
IP buffer
Denaturatation by addition of 
SDS sample buffer
A549 Cells
Nuclear Extract
Preclearing
Nuclear extract
Agarose Beads
ETBR
Rnase
30’ 30’
Ku70 antibody Agarose
beads
2 
incubation X-rays
Western Blot
2 h
h
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2.2.7.  Phosphorylation maintenance and dephosphorylation 
treatments 
Dephosphorylation and phosphorylation maintenance reactions were carried out 
using bacterial alkaline phosphatase (BAP) to mediate dephosphorylation and 
sodium ortho-vanadate plus sodium fluoride to maintain phosphorylation. 150 µg of 
nuclear extracts were incubated with 30 U of BAP for 30 min in 20 µl reactions at 
25°C prior to IP. NaF and Na3VO4 treatment was included in all steps of NE 
preparation and during IP. All buffers were supplemented with 10mM of NaF and 
5mM Na3VO4.  
2.2.8.  EMSA (Electrophoretic Mobility Shift Assay) 
EMSA was performed to measure the activity of purified DNA binding proteins. The 
DNA binding assay was performed in two-step reactions as explained below (2.2.8.1 
and 2.2.8.2). 
2.2.8.1.  End labelling of oligonucleotides with γ-32P-ATP 
The γ-32P source vial was thawed at RT for 30min. A reaction was assembled in an 
eppendorf tube, which contained annealed oligonucleotides OA/OB (17, 25 ng/ul), T4 
polynucleotide Kinase (10 U/µl), 10X T4 polynucleotide kinase forward buffer (buffer 
A), and MiliQ water (deionised, nuclease free). Reaction was placed after short 
centrifugation on a rack in the fume hood. Behind an acrylic shield in the fume hood, 
5 µl γ-32P from the source vial were removed carefully and added to the reaction 
mixture. The reaction was then incubated at 37°C for 30 min. After completion of the 
stipulated incubation period, unbound γ-32P was removed from the reaction using a 
QIAquick nucleotide removal kit. In the first step, 250 µl of PN1 buffer was added to 
the reaction and mixed. Then, the reaction was placed in the QIAquick column into a 
clean 2 ml collection tube and centrifuged at 6000 rpm. The radioactive flow through 
was appropriately discarded and 500 µl buffer PE was added and centrifuged for 1 
min at 6000 rpm. After discarding the radioactive flow through, the washing 
procedure was repeated with 500 µl of PE buffer. The column content was 
centrifuged in an empty tube for 1 min at 13000 rpm. Subsequently, the QIAquick 
column was placed in a clean 1.5 ml tube and 86 µl elution buffer was added and 
incubated for 1 min. Finally, the column was placed in an empty eppendorf tube and 
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centrifuged for 1 min at 13000 rpm. The eluate contained the radiolabelled oligos 
(activity was later measured in a scintillation counter). 
2.2.8.2.  EMSA (Assembly of the reaction) 
DNA end-binding activity was assessed by incubating purified PARP-1 with 10x 
EMSA binding buffer, Appendix (5), 1 µl radiolabelled oligos (0.2 ng/µl) and H2O up 
to 20 µl. This reaction mix was incubated for 20 min at RT in a fume hood. To 
achieve supershift, 1 µl (200 ng/µl) of anti-PARP-1 primary Mab was added to the γ-
32P-labelled DNA with the protein mixture and incubated for 15 minutes at RT. The 
reaction was stopped by adding 5 µl 6x DNA loading dye to the reaction. Reaction 
was electrophoresed on 6% polyacrylamide gel in 0.5x TBE buffer. These gels were 
set on pre-run for 30 min at 150 V. The samples were then loaded and run for 60 min 
at 150 V. Then the voltage was increased to 230 V and gels were run for another 90 
min. The gels were dried, aligned and exposed on a storage phosphor screen and 
analysed in the Typhoon scanner. For information about buffers and 
oligonucleotides, refer to Appendix (5).   
2.2.9.  Protein purification 
2.2.9.1.  Expression and purification of human PARP-1 
Cloning- The BAC constructs used for PARP-1 expression in Sf9 cells were a kind 
gift from Dr. Matthew Knight, Victorial University of Technology, Australia [125]. For 
the construction of this vector, PARP-1 was inserted into a pUC cloning vector. Then 
PARP-1 was excised from the pUC construct and cloned into pFAST BAC1 and 
pFastBacHTb (Invitrogen) at the XbaI restriction site. 
 
2.2.9.2.  Standard protein expression of human PARP-1 
The recombinant virus expressing human PARP-1 was generated by co-transfection 
of Sf9 cells with pFastBac1-PARP-1 or pFastBacHTb-PARP-1 by a BAC-to-BAC® 
Baculovirus expression system (Invitrogen). Recombinant Baculovirus stocks were 
generated and stored frozen.  
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2.2.9.3.  Medium Preparation and growth conditions 
Sf9 cells were grown at 27°C in spinner flasks in Grace’s insect cell medium (pH 6.1) 
including 100 mg/L penicillin and Streptomycin and supplemented with 10% fetal calf 
serum (heat-inactivated) with 50x stock (0.1665 g/ml) of Lactalbumin hydrolysate, 
50x stock–200 g/L yeastolate ultrafiltrate, dissolved in water and stored in the dark. 
 
2.2.9.4.  Overproduction and identification of PARP-1 
Sf9 cells were grown in spinner flasks to the concentration of 2-3 x 106 cells/ml, 
diluted to the density of 1.5 x 106 /ml with fresh growth medium containing virus stock 
at 2.5 MOI (multiplicity of infection), incubated and stirred gently for 48 hours. The 
expression of PARP-1 in infected cells was determined by SDS-PAGE (8%). After 
blotting of total cellular proteins PARP-1 was detected by Western blotting using a 
mouse monoclonal antibody raised against purified calf thymus PARP-1. 
 
2.2.9.5.  PARP-1 Purification  
Approximately 700 x 106 infected cells were lysed and homogenized by vortexing (3 x 
30 secs.) at 4°C with ice cold hypotonic homogenization buffer, which was enriched 
with protease inhibitors – 2 µg/ml aprotinin, 1mM benzamidine-HCl and 1µg/ml 
pepstatin. Cellular debris was removed by centrifugation for 20 min at 40,000 g at 
4°C. Endogenous DNA was removed by addition of 1 mg/ml Salmon sperm 
protamine sulphate (Bio medicals) followed by centrifugation for 20 min at 40,000 g 
at 4°C. The supernatant was precipitated by two steps of ammonium sulphate 
precipitation; first, with 0 - 30% (5.28 g/30 ml lysate) and second with 30 - 70% 
saturated ammonium sulphate (8.2 g/30 ml lysate). Ammonium sulphate precipitation 
was performed on ice under continuous stirring. The precipitated proteins were 
dissolved in ice-cold chromatography extraction buffer A, Appendix (6), and kept for 
dialysis overnight in buffer containing 25 mM NaCl. The lysate was then loaded onto 
a DNA-single strand cellulose column equilibrated (five column volume) with 
chromatography buffer A at a flow rate of 0.2 ml/min. Elution was performed with a 
step gradient at 250, 750 and 1000 mM NaCl using chromatography buffer B (Buffer 
A + 1M NaCl). PARP-1 was eluted at 750 mM NaCl. Purified PARP-1 fractions were 
further used for SDS-PAGE analysis, protein concentration determination (Bradford 
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assay) and for determination of enzymatic activity. For further information about the 
buffers refer to Appendix (6). 
2.2.10.  Activity Assays for determination of PARP-1 activity 
2.2.10.1.  Non-Radioactive enzymatic assay for PARP-1 activity 
The described assay is a non-radioactive Western blot-based PARP-1 assay. The 
activity measurment is based on the fact that when PARP-1 encounters DNA breaks, 
it activates itself and adds ADP-ribose units on itself using NAD+ as a substrate. In 
the assay, PARP-1 auto-poly-ADP-ribosylation is measured using anti-poly-ADP-
ribose antibodies. The intensity of the signal generated is proportional to the PARP-1 
activity present in the sample. The standard reaction mixture contained 10x NHEJ 
buffer, Appendix (5), 50ng SalI-digested pSP65 plasmid, 4mM NAD+, the indicated 
amount of purified histone (H1.2), 5 ng of purified Ligase3-β with 1mM ATP and 50 & 
100 ng of PARP-1 in a total reaction volume of 20 µl incubated at 37°C. The reaction 
mixture was incubated at 37°C for 10 min. and then 5 ng of Ligase3-β with 1mM ATP 
was added to each reaction for a final volume of 20 µl and further incubated for 20 
min at 37°C. The samples were then removed and the reaction was stopped by 
adding 2x SDS loading buffer and further sonicated for 15 min at 80°C. Products 
were analyzed on 6% PAGE at 100V for 2 hours and then blotted onto HyBond-P 
PVDF membrane. For immunodetection, an anti-polyADP-ribose antibody was used 
and was detected using the ECL Western blotting Kit. 
 
2.2.10.2.  Radioactive enzymatic assay for PARP-1 activity 
EMSA was carried out with purified PARP-1 protein as described above. 
2.2.10.3.  Dot-Blot 
Dot-Blot was performed to check the activity of purified PARP-1 in the presence and 
absence of histone H1. Aliquots (6 µl) from the reactions of non-radioactive PARP-1 
assay were stored to run a dot-blot. The samples were diluted with SDS (5%) and 
sonicated for 15 min at 80°C. A nitrocellulose membrane (Protran BA 85, 0.45 µm) 
was activated by rinsing with water and left to semi-dry. 1 µl sample was loaded onto 
the semi-dried membrane. The membrane was then incubated in blocking buffer 
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(same as for Western blot) for 30 min and then with an anti-polyADP-ribose antibody 
that was detected as described above. 
2.2.11.  Expression and purification of human Ku 
Cloning- BAC constructs for Ku70 and Ku80 were a kind gift from Dr. William S. 
Dynan (University of Georgia, GA). Expression of Ku70 and Ku80 was achieved by 
co-transfection of Sf9 cells with the corresponding recombinant viruses. Recombinant 
Baculovirus stocks were generated and stored frozen. The method of media 
preparation and the growth conditions, as well overexpression and detection of Ku 
was as described for PARP-1. 
2.2.11.1.  Ku purification 
Approximately 850 x 106 infected cells were lysed with Ku lysis buffer, Appendix (6). 
The cells were then mixed gently and incubated on ice for 30 min. The lysate was 
then centrifuged at 4250 x g for 15 min at 4°C. The supernatant (S1) was transferred 
to two new tubes. The supernatant was centrifuged at 20,000 rpm (48284 x g) for 1 h 
in a Beckman Avanti J20XP centrifuge, rotor JA-25.50, at 4°C. The supernatant (S2) 
was transferred to new tubes, the volume was measured and 50 µl sample aliquots 
were taken for analysis. The supernatant was ultra-centrifuged at 35000 rpm for 0.5 h 
at 4°C (combined supernatant S3). The proteins in the lysate S3 were precipitated 
with 70% ammonium sulphate, for example - (27.9 g/64 ml). The samples were then 
centrifuged at 4°C for 10 min at 15000 rpm in a Beckman Avanti J20XP centrifuge. 
The ammonium sulphate precipitated pellet was then resuspended with 5 ml Ku-CB 
buffer + 1M NaCl and then ultracentrifuged at 35000 rpm for 0.5 h at 4°C. 
Supernatant (S4) was collected and aliquots removed for determining protein 
concentration using the Bradford assay and for SDS-PAGE analysis. The 
supernatant (S4) was then filtered through 0.2 µm filter before loading onto a column 
for purification utilizing an Aekta FPLC. For this purpose, the filtered supernatant was 
loaded onto a Superdex 200 column (HiLoad 26/60) equilibrated with Ku-CB + 1M 
NaCl. The fractions obtained were run on 10% SDS PAGE and Western blotted to 
check the presence of the Ku70/80 heterodimer. All fractions containing Ku70/80 
heterodimer were pooled together and dialysed against 0.2 M KCl in Ku-CB buffer. 
The dialysed samples were filtered through 0.2 µm filter. Sample was loaded onto a 
single stranded (ss) DNA-cellulose column (self packed CV 2 – 3 ml) equilibrated 
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with 0.2 M KCl in Ku-CB buffer. A linear gradient program was designed to run from 
0.2 M – 1 M NaCl, 5 CV. Ku eluted between 0.4 - 0.5 M NaCl. Fractions were 
collected and analysed by SDS-PAGE to determine those containing Ku. These 
fractions were then pooled together and dialysed against 0.1 M KCl in (Ku-CB) 
buffer. Dialysed samples were loaded onto a 1 ml HiTrapTM Heparin HP column, pre-
equilibrated in Ku-CB, 0.1M KCl. Elution was preformed with a step gradient: 0.1, 0.2, 
0.3,and 1.0 M KCl. Ku eluted in the 0.3 M KCl fraction. Purified fractions were used 
for SDS-PAGE analysis, protein concentration determination (Bradford assay) and 
for determination of enzymatic activity by EMSA utilizing γ-32P-labelled 
oligonucleotides as described earlier. For further details refer to Appendix (6). 
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3.  Results 
3.1.  Introduction 
3.1.1.  Purpose of the Study 
It is widely accepted that the MRN complex has an essential role in sensing DSBs. 
On the other hand, a sensing role for Ku is only occasionally suggested and it 
remains open how Ku and the ensuing NHEJ allows the function of MRN, either 
within NHEJ or HRR.  
It has been reported that Mre11 physically interacts with the Ku heterodimer. 
However the functional significance of this interaction remains unclear. Several 
hypotheses can be formulated on the basis on these interactions. Although Ku is 
most likely the first molecule to bind and stabilize the open DNA ends, due to its ring 
shaped structure, it will remain trapped on the repaired DNA after completion of 
NHEJ. We hypothesized that Ku removal is accomplished in an Mre11 dependent 
manner. Trapped Ku may also help in the recruitment of the MRN complex and may 
also contribute to the development of a full blown DNA damage response and to DSB 
repair pathway selection.  
To begin addressing the functional significance of Mre11/Ku interactions, we 
developed and performed in vitro and in vivo experiments based on 
immunoprecipitation reactions, in order to identify first interaction determinants. Most 
experiments described here are based on pull down assays utilizing purified proteins 
or protein extracts isolated from normal cells or from mutants with known defects in 
DSB repair. Our results confirm previously reported interactions between Ku and 
Mre11 and shed light to the role of these interactions in DSB repair process and the 
activation of DNA damage response cascades. 
 
3.1.2.  Purification and enzymatic activity of Ku 
To study the interactions between Ku and Mre11, we utilized purified Ku. 
Recombinant Ku70 and Ku80 proteins were expressed in Sf9 cells using baculovirus 
constructs and were prepared as described under Materials and Methods. 
Purification was initiated with gel filtration (size exclusion chromatography) to 
separate large from small proteins using a Sephadex200 pre-packed column. 
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Indicated fractions (B9 - D2) were collected from the first chromatography step, were 
run on 10% SDS–PAGE to identify the fractions containing the low and high 
molecular weight proteins (Figure 1.1.1 A). Fractions B12 to C8 were pooled, 
dialysed against low salt (200mM NaCl) dialysis buffer and loaded on DNA cellulose 
column.  
In the purification step, we utilized the DNA binding properties of Ku. Affinity 
purification was performed using a DNA cellulose resin (Figure 1.1.1 B). A linear 
gradient elution scheme was devised between 200 - 1000 mM NaCl and peak 
fractions (B12 - C12) of the chromatogram checked on SDS-PAGE. The presence of 
the Ku70 was confirmed by Western blot using an anti-Ku70 antibody (Figure 1.1.1 
C). Fractions containing Ku (C4-C10) were mixed and dialysed against a buffer 
containing 200mM KCl, aliquoted and stored at -80°C. In further experiments, the 
DNA binding activity of the purified heterodimer was determined. 
Electrophoretic Mobility Shift Assay (EMSA) was used to determine the enzymatic 
activity of purified Ku. To increase the sensitivity of detection, EMSA was performed 
with radio-labelled 25bp DNA oligos. This approach allows the use of small amounts 
of both protein and DNA.  
EMSA is based on the concept that a protein-DNA complex migrates slower than the 
free linear DNA fragments when subjected to a non-denaturating continuous electric 
field polyacrylamide or agarose gel. As the rate of DNA migration is retarded and the 
bands appear shifted when bound to protein, the assay is also referred to as “gel shift 
assay” or “gel retardation assay”. A representative phosphor image of an EMSA 
experiment carried out with different amounts of purified Ku is presented in Figure 
1.1.2.  
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Figure 1.1.1 
Purification of Ku:  
A) SDS-PAGE of protein fractions collected after gel filtration 
chromatography. Peak fractions from the corresponding chromatogram 
(B9-D2) were analyzed. M – Pre-stained protein ladder.  
B) SDS-PAGE of collected fractions from affinity purification. The eluted 
fractions from DNA cellulose column corresponding to the peak in 
chromatogram (B12 - C12) were run on 10% SDS PAGE and were stained 
with Coomassie brilliant blue.  
C) Western blot with anti-Ku70 antibody of affinity purified Ku fractions. 
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Figure 1.1.2 
Determination of Ku DNA-end binding activity: 
From left to right; first lane represents Ku fraction C4 (6 ng of purified Ku70/80) 
bound to 25 bp oligos gives a shift when compared to low molecular weight signal 
of only oligos (positive control) on extreme right lane. Second lane shows a super 
shift from C4 fraction when Ab against Ku70 was added. Third and fourth lanes 
are the same with C4 fraction in double the concentration (12ng). Next two lanes 
show again a shift and super shift with another fraction (C10). Last lane in right 
shows a low molecular weight signal (25bp double stranded DNA) of unbound 
oligonucleotides.
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The Figure shows that free DNA oligos migrate at the bottom of the gel, while in the 
presence of Ku, a significant shift is observed. Additionally, to confirm that the DNA 
binding protein in our EMSA reactions is indeed Ku, the reactions were 
supplemented with anti-Ku70 antibody. Binding of antibody to Ku70 resulted in a 
super-shift, identified as a slowly migrated DNA-protein fraction above the DNA-
Ku70/80 shift. The nearly complete supershift suggests the absence from the 
fractions of other DNA binding proteins.  
 
3.1.3.  Ku binds to DNA in a DNA length dependent manner 
As mentioned above, Ku is one of the first molecules that binds to DNA ends after 
the generation of DSBs. The crystal structure of Ku revealed a ring shaped molecule, 
which contributes to its DNA interaction characteristics. Due to this conformation, Ku 
threads on free DNA ends and may serve as a loading platform for other factors of 
NHEJ, primarily though for DNA-PKcs. Additionally, Ku slides inwards the DNA thus 
generating space for another Ku molecule to bind. 
Using purified components and protein extracts we developed an in vitro 
oligonucleotide-based assay, which in some ways mimics the situation when cells 
are exposed to IR. In the following experiments oligonucleotides with different lengths 
were utilized, assuming that larger DNA will bind a larger number of Ku molecules, 
thus augmenting the probability of DNA bound Ku to interact with other repair factors. 
To determine how different sized oligos modulate the interaction between Ku and 
Mre11, the IP reaction was supplemented with 25, 50 and 100 bp long oligos that 
were incubated with nuclear extract (NE) isolated from A549 cells or nuclear extract 
obtained from Ku80 (Xrs-5 and Xrs-6) deficient mutants. 
The presence of Mre11 and Ku in the isolated protein extracts was determined by 
immunobloting. For this purpose, a nuclear extracts from A549 and Ku80 deficient 
cells were prepared as described under Materials and Methods and proteins were 
resolved on SDS-PAGE. Mre11 and Ku70 were detected by Western blot analysis 
with the corresponding antibodies.  
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Figure 1.2.1 
Western Blot analysis representing the level of Mre11 and Ku70 in nuclear 
extracts isolated from A549 and Xrs-5 cells: 
 
A) Mre11 expression level in Xrs-5 (Ku80 defective CHO cells) and A549 
cells.  
B) Ku70 expression in Xrs-5 and A549 cells. Exponentially growing A549 and 
Xrs-5 cells were used for extract preparation as described under Materials 
and Methods. NE was resolved on 10% SDS-PAGE and blotted onto 
PVDF membrane for detecting the Mre11 or Ku70 (the level of this 
component of Ku is undetectable in the absence of the Ku80 component). 
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An anti GAPDH antibody was used as loading control (Figure 1.2.1). The results 
clearly demonstrate that the level of Mre11 in Ku70 deficient hamster cells is about 2 
to 3 folds lower than the Mre11 level detected in human A549 cells. Ku70 was 
undetectable in xrs-5 cells as a result of the Ku80 deficiency that causes depletion of 
this KU component as well, while in A549 cells, a prominent band, corresponding to 
Ku70 was observed.  
Further IP experiments were carried out with A549 or Xrs-6 NE. In the first reaction 
set with A549 NE, reactions were incubated in the presence of Mre11 antibody, IP 
beads and DNA oligos of different size. The immunoprecipitated material was 
resolved by SDS-PAGE and the amount of Ku co-immunoprecipitated detected by 
Western bloting using an anti-Ku70 antibody. In the second reaction set Mre11 was 
immunoprecipitated from the Xrs-6 nuclear extract and afterwards the beads 
containing bound Mre11 were transferred to another reaction supplemented with 
purified Ku and DNA oligos of different sizes. The latter protocol allows the evaluation 
of Ku/MRE11 interactions starting with a protein fraction enriched in Mre11, but which 
has not interacted with Ku. Immunoprecipitated material from the last step of this 
protocol was resolved on SDS PAGE and Ku was detected using an anti-Ku70 
antibody. The anti-Mre11 antibody was used in both IP protocols also as a loading 
control and the intensity of the signal obtained with this antibody was equated to the 
amount of immunoprecipitated Mre11. 
Western blots presented in Figure 1.2.2 clearly demonstrate that in A549 NE, Ku 
interacts with Mre11 even in the absence of DNA. However, in the presence of DNA 
the interaction observed between the two proteins increases significantly in a DNA 
size dependent manner. To quantify the level of Ku immunoprecipitated with Mre11, 
the signal corresponding to Ku70 was normalized against the Mre11 signal and the 
values obtained plotted as a function of the DNA oligo size (Figure 1.2.2 B). The 
amount of Ku70/80 immunoprecipitated together with Mre11 was highest when 100 
bp oligos were used  
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Figure 1.2.2 
Ku70 binds to DNA oligos in a DNA size dependent manner: 
A) Western blot analysis using a Ku70 Ab when IP was performed with Mre11 
Ab in A549 NE using the indicated oligonucleotides. After Ku visualisation, 
the membrane was re-probed with an Mre11 Ab and the signal was used 
as a loading control. 
B) Ku70 signal was normalized against the Mre11 signal and the values 
obtained are shown. No further absolute calibration of the Westerns was 
performed to derive actual amounts of protein and therefore the values 
obtained should only be used for the comparison between samples. 
C) Western blots analysis with Ku70 Ab when IP was performed with Mre11 
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in our reaction. In the case of Mre11 being pulled down from Xrs-6 NE and incubated 
with purified Ku70/80 the pattern of interaction indicates that DNA attenuates a rather 
strong constitutive Mre11/Ku interaction. This observation may reflect a shift in the 
interaction equilibrium from Mre11/Ku to interactions between Ku and DNA. 
However, even under these conditions and in the presence of DNA, Mre11-Ku 
interactions were stronger with increasing length of the DNA oligo. This supports the 
view that Ku interacts with Mre11 in vitro, and these interactions are promoted by 
DNA. 
 
3.1.4.  Introduction to in vivo experiments 
The results of our in vitro experiments lead to the following conclusions: First, the 
interaction between Mre11 and Ku is influenced by the presence of DNA; and 
second, that this interaction is influenced by the size of the DNA oligos used. 
Since the interaction between Mre11 and Ku has been previously reported [55], we 
decided to examine whether these interactions are DNA damage dependent and also 
how these interactions are influenced by the proteins involved in the DDR response. 
To begin with our experiments, we selected the human lung carcinoma cell line 
(A549), which exhibits decreased repair of mismatched DNA bases, but express a 
wild type p53 - contrary to most human carcinoma cell lines available. The presence 
of a functional p53 in A549 cells is beneficial to our studies, since it leaves intact 
several important DNA damage signalling cascades. This property enables us to 
investigate the role of Ku/Mre11 interactions in developing full checkpoint response 
and in modulating DSB repair by switching or selecting between available repair 
pathways. Xrs-6 cells are Chinese hamster ovary (CHO) with a defect in Ku80, 
mutant in p53, highly radiosensitive and defective in DSB repair (D-NHEJ) [122]. 
 
3.1.4.1.  Investigation of Ku/Mre11 interactions in intact cells  
To investigate the functions of Mre11 and Ku, the initial players of DNA damage 
response in DSBs repair, and to elucidate the significance of their interaction, we 
carried out IP reactions in extracts of irradiated A549 cells. We utilized agarose 
beads pre-coated with mouse/rabbit IgG antibody, which have high binding specificity 
towards mouse/rabbit-originated antibodies - e.g. mouse monoclonal anti-Ku70 Ab or 
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rabbit polyclonal anti-Mre11 Ab. Initially, immunoprecipitation was carried out with an 
Ku70 Ab in non-irradiated A549 whole cell extract and Mre11 was detected in the 
immunoprecipitates by Western bloting. As expected, Mre11 was detectable in A549 
cell WCE, but not in Xrs-6 cells WCE (Figure 1.3). This preliminary experiment 
revealed an IR independent interaction between Ku and Mre11, which served as a 
platform for further investigations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1.3 
Co-Immunoprecipitation of Ku and Mre11 from non-irradiated cells: 
Western blot signal detected with and anti-Mre11 Ab when IP with a anti-Ku70 AB 
was carried out in WCE prepared from exponentially growing A549 and Xrs-6 
cells. The first lane represents 10 µg of A549 WCE which was loaded as a 
positive control. The second lane shows absence of Mre11 signal when 
immunoprecipitation is carried out in Xrs-6 WCE. The third lane represents the 
Mre11 signal detected after IP in A549 cell extracts. Last lane depicts the singal 
obtained when only beads are loaded. 
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3.1.5.  The Ku/Mre11 interaction is enhanced in NE of A549 cells. 
Most proteins involved in DDR exhibit predominantly nuclear localization. To check, 
Ku/MRE11 interactions in different sub-cellular compartments, irradiated or non-
irradiated A549 cells were biochemically fractionated into cytoplasmic (CE), nuclear 
(NE) and chromatin bound (NP) extracts and the interaction between MRE11 and Ku 
examined using procedures similar to those outlined above.  
Figure1.4.1 A shows a representative Western blot indicating that the maximum 
binding of Mre11 to the IP beads was observed in NE, a result that could also be 
confirmed by densitometry analysis, Figure 1.4.1 B. Here, it is necessary to mention 
that the more prominent Mre11 binding to IP beads in the NE extracts, may be due to 
minute differences in the amount of CE, NE ad NP loaded in each lane . 
Nevertheless, the same pattern of Mre11 binding to IP beads was observed in 
extracts of irradiated cells. 
In the next experiments the ability of Mre11 antibody to immunoprecipitate Ku70 from 
the different A549 sub-cellular fractions was tested. The results from these 
experiments show that Ku70 immunoprecipitation does not strictly depend on the 
origin of the protein extracts, especially when the cells were irradiated (10 Gy) 
(Figure 1.4.2). Based on these results all further co-immunoprecipitation reactions we 
carried out in NE. 
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Figure 1.4.1 
NE is ideal for IP experiments: 
A) Detection of Mre11 binding to IP beads. CE, NE and NP were used and 
after IP Mre11 was detected by Western blotting. Extracts from irradiated 
(lower panel) and non-irradiated (upper panel) A549 cells were tested. 
B) Bar graph showing the quantification of the above results based on the 
intensity of Mre11 signal. 
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Figure 1.4.2  
Interdependency between Mre11 and Ku interactions: 
A) Western Blot for Ku70 when IP was performed using an anti-Mre11 Ab in 
A549 CE, NE and NP. The Upper panel represents IP performed with non-
irradiated A549 cells and the lower panel IP in irradiated cells. The first 
lane in the upper and lower panels represent positive controls, where A549 
WCE is directly loaded. Samples were run on SDS-PAGE and blotted onto 
PVDF membrane for the detection of Ku70 protein. 
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3.1.6.  The interaction of Mre11 and Ku70 is enhanced after IR 
The above results confirm the constitutive interaction between Ku and Mre11 and 
suggest that this interaction is enhanced after induction of DNA damage by IR. Since 
the latter finding is novel and has important ramifications for our understanding of the 
DDR, we designed experiments to analyze further this effect.  
In the following experiment, we exposed cells to 2 and 4 Gy of IR and after 10 min 
incubation cells were processed for NE preparation. The short incubation time after 
IR was chosen on the assumption that both interacting partners are recruited to 
DSBs within minutes after IR [108]. Indeed, fast kinetics of Mre11 foci formation and 
the nearly immediate recruitment of Ku to DSBs have been reported [94]. 
The Western blot results shown on Figure 1.5 A clearly demonstrate that in the 
absence of radiation only a small amount of Mre11 co-immunoprecipitates with Ku70. 
This amount increases significantly after IR even for short incubation times.  
To validate further this interaction, we performed the same experiment as above but 
instead of immunoprecipitating with an anti-Ku70 antibody and checking for Mre11 in 
the immunoprecipitated material, an Mre11 antibody was used in the IP reactions 
and the immunoprecipitates were checked for Ku70 (Figure 1.5 B). The results of this 
experiment are similar to the results obtained from above.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 - 53 -
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5  
The interaction between Mre11 and Ku is enhanced after IR: 
A) Western blot of Mre11 in IP reactions carried out with and anti-Ku70 Ab 
using A549 NE from cells exposed to 2 and 4 Gy IR. The first lane shows a 
positive control signal of Mre11 in A549 WCE, the second lane shows a 
control reaction, exclusing nonspecific binding of Mre11 to IP beads, the 
third lane shows a negative control showing no MRE11 signal in Xrs-6 NE, 
the fourth lane shows IP with non-irradiated cells and the fifth and sixth 
lanes the IPs performed in irradiated samples. 
B) Western blot of Ku/Mre11 interaction using an anti-Mre11 Ab for IP and 
and anti-Ku antibody for detection. Lanes are as explained in A. 
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3.1.7.  The Ku/Mre11 interaction persists after IR 
 
In the previous experiments, the dose dependent effect of IR on Ku/Mre11 interaction 
was investigated at 10 min after irradiation. This time was selected on the 
assumption that the interaction between the two proteins should be most prominent 
immediately after the induction of DSBs in the DNA. The fast formation of the 
Ku/Mre11 complex also suggests that the two proteins could modulate the efficiency 
of DSB repair by somehow regulating either NHEJ or HRR. To examine for how long 
the interactions between Ku and Mre11 persist after IR, we followed Ku/Mre11 
interaction as a function of time after irradiation with 4 and 8 Gy. Results summarized 
in Figure 1.6 show a time dependent interaction between the two proteins, when IP 
was performed with a anti-Ku70 antibody. Densitometric analysis of Western blot 
data shows that the Ku/Mre11 interaction increases with time after IR reaching a 
plateau at 4h in the case of 8 Gy with no significant decrease at later times. However, 
at later times, the signal generated from irradiated samples was similar to that 
measured in non-irradiated samples at the same time suggesting recovery. 
Curiously, the signal measured in non-irradiated samples increased during the 
course of the experiment and it was not possible to identify parameters responsible 
for this unexpected response. As the peak of interaction was achieved at 2h, it was 
decided to perform all subsequent experiments after this incubation time.  
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Figure 1.6 
Kinetics of Mre11/Ku interaction at different time points post irradiation: 
A) Western blot analysis with Mre11 Ab showing the kinetics of Mre11/Ku 
interaction as detected by IP performed with an anti-Ku70 Ab from A549 
NE prepared at different times post IR. First lane (0Gy, 0hr) and last lane 
(0Gy, 8hr) show Mre11 signal in reactions of non irradiated cells. 
B) Values from densitometric analysis of the signal intensity of Mre11. 
C) Western blot analysis with Mre11 Ab depicting recruitment kinetics 
obtained when IP was performed with Ku70 Ab and 8 Gy IR. 
D) Densitometric analysis of Mre11 signal intensity plotted in line graph 
format. 
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3.1.8.  The Ku/Mre11 interaction is stable and is not mediated by 
DNA  
Both Ku and Mre11 are DNA binding proteins; therefore the next step was to 
investigate whether the observed interaction and effects are DNA dependent events. 
For the following assay, we selected the well known DNA intercalating agent 
ethidium bromide (EtBr) to investigate whether DNA or RNA serve as a binding 
scaffold for both proteins. In other words, we wished to exclude that the observed 
interaction did not derive from the independent binding of each protein on DNA or 
RNA. Nuclear extracts were incubated with EtBr and RNAase prior to IP (For 
concentrations of EtBr and RNase used, see under Materials and Methods). 
Although the interaction between Ku and Mre11 was somewhat attenuated in the 
presence of EtBr, the interaction was not completely abrogated and the effect of 
radiation remained clearly detectable. Thus, we conclude that Mre11/Ku interaction is 
not indirect, mediated by the independent binding of the proteins on DNA. The results 
obtained are summarized in (Figure 1.7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 
Validation of Mre11/Ku interaction: 
Western blot of interacting Mre11 when IP with an anti-Ku70 Ab using A549 cells 
was carried out in the presence or absence of EtBr and RNase. First lane shows 
a positive control signal of Mre11 in A549 WCE, second and third lanes show 
Mre11 signal when cells were radiated with 2 and 4 Gy of X-rays in absence of 
EtBr and Rnase. The next two lanes show the same reactions carried out in the 
presence of EtBr and RNase. The last two lanes show control reactions with Xrs-6 
NE and A549 NE showing the lack of non-specific binding of Mre11 to the IP 
beads.  
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3.1.9.  The entire MRN complex takes part in the interaction with Ku 
In the cellular environment the Mre11 protein does not exist as a single molecule but 
is in a complex with Nbs1 and Rad50. All three proteins form the MRN complex, 
which has an important function in DSB repair and DDR signalling. The aim of the 
next experiments was to investigate whether other partners from the MRN complex 
take part in the interaction with Ku. After immunoprecipitation with an anti-Ku70 
antibody the immunodetection of Rad50 and Nbs1 was accomplished. It can be 
observed from Figure 1.8 that Nbs1 and Rad50 also take part in the interaction, thus 
implicating the whole MRN complex in the interaction with Ku. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 
Western Blot analysis of Rad50 and Nbs-1 after IP of Ku:  
Western blot of Nbs1 and Rad50 when IP was performed with an anti-Ku Ab. First 
lane in both panels shows the positive control with A549 WCE, the second and 
third lanes represent IP with an anti-Ku70 Ab performed with cells irradiated with 
2 and 4 Gy. 
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3.1.10.  Are other partners involved in the KU/MRN interaction? 
To check the specificity of the interaction between MRN and Ku and to investigate 
whether other proteins are also involved in this interaction, further IP experiments 
were performed. The blots were probed with antibodies against proteins involved in 
DDR, such as ATM, PARP-1, 53BP1 and Mdc-1. It was found that along with the 
MRN complex, other DNA damage sensors such as PARP-1 and ATM were also 
involved in the complex (Figure 1.9 A). These proteins are known interacting partners 
of Mre11 and Ku, so it is not surprising that the signals of those proteins are found in 
the Ku70 immunoprecipitated material. Surprisingly, Mdc-1 and 53BP1, which are 
involved in the mediation of DDR, were not found in the Ku/MRN complex, 
suggesting that the observed interactions may reflect the initial DSB response.  
The specificity of the interaction between Mre11 and Ku was confirmed by analyzing 
the immunoprecipitates with anti-Rad51 antibody. It is known that the active form of 
the Rad51 protein forms a right helical nucleoprotein filament along the ssDNA 
regions surrounding the processed DSBs. The formation of a Rad51 nucleoprotein 
filaments needs extensive processing of the ends and it is now known that the MRN 
complex, together with CtIP plays an important role in this process. As a result of the 
participation of the MRN complex in the processing of DNA ends during DSB repair, 
it is reasonable to speculate that the entire repair machinery may interact with the 
primary DSB sensors, especially if they persist at the damaged sites. The Rad51 
recombinase, which does not participate in NHEJ, failed to interact with Ku, which 
strengthened the significance of Ku/MRN interaction for D-NHEJ and signaling 
(Figure 1.9 B).  
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Figure 1.9  
DDR proteins involved in the Ku/MRN interaction:  
A) IP reactions with an anti-Ku70 Ab were resolved on 10% SDS-PAGE and 
the blots were probed with anti-ATM, anti-MDC1, anti-PARP-1 and anti-
53BP1 antibodies. 
B) Rad51 is not part of the KU/MRN complex. The membranes from Western 
blots showing the dose and time dependent interaction of Mre11 and Ku 
were stripped and re-probed with anti-Rad51 antibody.  
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3.1.11.  Cells defective in DNA-PKcs show no radiation-dependent 
enhancement of Ku/Mre11 interaction 
It is well known that Ku participates in a complex with DNA-PKcs to form the DNA-PK 
holoenzyme, which is functional in D-NHEJ. As DNA-PKcs is a kinase that 
phosphorylates a number of proteins including Ku and itself, we investigated whether 
the interaction between Ku and Mre11 requires DNA-PKcs. For this purpose we used 
M059J and M059K cells. These cells originate from the same glioblastoma tumour, 
but have widely different DNA-PKcs levels. Thus, as a result of a frame-shift 
mutation, the expression level of DNA-PKcs is in M059J cells about 200 times lower 
than in M059K cells and are deficient in D-NHEJ.  
For experiments, we prepared NE from M059J and M059K cells and used them in IP 
reactions with an anti-Ku70 antibody. Interestingly, we found that DNA-PKcs 
defective cells fail to show any enhancement in Mre11/Ku interaction after IR. On the 
other hand, a dose dependent increase in the interaction between Ku and Mre11 was 
observed in the DNA-PKcs proficient M059K cells (Figure 1.10 A). This result 
suggests possible regulation of the Mre11/Ku interaction by DNA-PKcs. The 
quantification of the Western blots demonstrates that in DNA-Pkcs deficient cells, the 
Mre11/Ku70 interaction becomes attenuated with dose as compared MO59K cell, 
which express functional DNA-PKcs and where a clear increase is observed (Figure 
1.10 A). On the other hand, a higher level of constitutive (IR-independent) interaction 
between Mre11 and Ku is observed in M059J cells, suggesting multi-level regulation 
of this interaction by DNA-PKcs. 
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Figure 1.10  
(A) Mre11/KU interaction in DNA-PKcs deficient cells: 
  
A) Western blot analysis of Mre11 in DNA-PKcs+/+ cells when IP was performed 
with an anti-Ku70 Ab. 
B) The ratio of Mre11 to Ku signal intensity, determined by densitometric 
analysis of M059J and K Western blots, shown in bar graph form. 
C) Mre11 signal detected through Western blot in DNA-PKcs-/-cells.  
D) Bar graph generated by calculating the ratio between Mre11 and Ku70 
signal intensities. 
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As it was observed in M059J and K cell lines that the interaction between Mre11 and 
Ku is dependent on DNA-PKcs in irradiated cells, we carried out an experiment 
utilizing another DNA-PKcs deficient cell line, HCT116 DNA-PKcs-/- along with its wild 
type counterpart. These cells are human adenocarcinoma cells and the defect was 
generated by disrupting DNA-PKcs through gene targeting (exon 81-83 was deleted) 
[126]. HCT116 wild type is an immortalized and transformed cell line; it is diploid, has 
a stable karyotype and is wild type for most known DNA repair mechanisms. For the 
following experiment, we prepared NE of HCT116 wild type and HCT116 DNA-PKcs 
deficient cells and utilized them to perform an IP with an anti-Ku70 Ab. The results 
obtained in this pair of cells were similar to those of M059J and M059K and show 
that DNA-PKcs deficiency attenuates the radiation-dependent interaction between Ku 
and Mre11. The results of this experiments are summarized in Figure 1.10 B. 
Western blots were densitometrically analysed and the ratio of Ku70 to Mre11 signal, 
plotted as a bar graph (Figure 1.10 B). The quantitation of the Western blots clearly 
shows that the level of Mre11-Ku70 interaction is more than 4-fold decreased in 
comparison to signal in HCT116 wild type cells, which expresses functional DNA-
PKcs (Figure 1.10 B). 
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Figure 1.10  
(B) Effect of DNA-PKcs on Mre11/KU interaction (continued): 
 
A) Western blot analysis of IP performed with an anti-Ku70 Ab and detection 
with Mre11 Ab in DNA-PKcs+/+ HCT116 cells. 
B) The ratio of Mre11 to Ku signal, as determined by densitometric analysis 
and plotted in the form of a bar graph. 
C) Mre11 signal detected through western blotting in DNA-PKcs-/-cells. 
D) Bar graph was plotted by calculating the ratio between Mre11 and Ku70 
signal intensities. 
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3.1.12.  ATM defective cells shows no radiation-dependent 
Mre11/KU interaction 
A key signalling function of the MRN complex is the recruitment and activation of 
ATM (ataxia-telangiectasia-mutated) kinase, which then initiates a cascade of 
phosphorylation events that leads to signal amplification, cell cycle arrest and DNA 
repair. The MRN complex acts as DNA damage sensor and an upstream regulator of 
ATM activity. The MRN complex also plays a crucial role downstream of ATM in DSB 
checkpoint signalling. Since the MRN complex seems to be important in the 
activation of ATM, we investigated the effect of ATM on KU/MRN interaction. For this 
purpose, we utilised an ATM deficient cell line, AT5BIVA. AT5BIVA are skin 
fibroblasts derived from AT individuals and were immortalized by transfection with the 
SV40 large T-antigen [124]. For experiments, we prepared NE of A549 and AT5BIVA 
cells and used them to perform IP with an anti-Ku70 Ab. Time course analysis of 
extracts of irradiated AT5BIVA cells shows the same response for Ku/Mre11 
interaction as DNA-PKcs deficient cells. Quantitative Western blot analysis for both 
Ku and Mre11 signal, confirms this observation. Figure 1.11 shows that there is no 
IR-dependent boost in Mre11/Ku interaction in ATM defective cells when compared 
to their wild type counter part. 
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Figure 1.11  
Effect of ATM on IR-dependent Mre11/KU interaction: 
A) Western blot analysis of IP performed with an anti-Ku70 Ab and detection 
with anti-Mre11 Ab in A549 NE, in cells exposed to 4 Gy X-rays. 
B) The ratio of Mre11 to Ku signal (A549) was determined by densitometric 
analysis and plotted as a bar graph. 
C) Mre11 signal detected by Western blot in ATM deficient AT5BIVA cells. 
D) Bar graph plotted on the basis of Western blot densitometric analysis for 
ATM deficient cells. 
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3.1.13.  Preservation of phosphorylation compromises MRE11/KU 
interaction 
The above experiments suggest that DNA-PK and ATM mediated phosphorylation 
regulate somehow the Mre11/Ku interaction. Hence, we designed an experiment to 
investigate whether maintaining phosphorylation with phosphatase inhibitors such as 
sodium orthovanadate (Na3VO4) with sodium azide (NaF) modulates the effect. We 
also determined the effect of dephosphorylation using bacterial alkaline phosphatase 
(BAP). For all experiments, A549 cells were used. The treatment schemes used in 
these reactions are outlined under Materials and Methods. Figure 1.12 demonstrates 
the effect of phosphorylation and de-phosphorylation on the radiation dependent 
interaction between Mre11 and Ku. A control reaction which is carried out without any 
treatment shows the expected dose-dependent interaction of Mre11 with Ku. The 
presence of BAP in the IP reaction completely abrogates and even reverses this 
interaction. IP performed in the presence of Na3VO4 and NaF shows a decrease in 
the overall the interaction but the IR-dependent aspect remains unchanged or even 
more pronounced. Interestingly, when BAP is used in conjunction with Na3VO4 + NaF 
the effect of the latter cocktail dominates and a robust IR-dependent Mre11/KU 
interaction is observed. 
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Figure 1.12 
Effect of phosphorylation status on Mre11/Ku interaction: 
A) Western blot analysis of Mre11 in control reaction when IP with an anti-Ku70 
Ab was carried out in extracts of cells exposed to 0 and 4 Gy IR. 
B) Mre11 signal when IP was performed in presence of BAP. 
C) Mre11 signal when IP was performed in the presence of Na3V04 and NaF. 
D) Mre11 signal when IP was performed in presence of BAP + Na3V04 and NaF.  
E) Bar graph showing the quantification of above results based on the ratio of 
Mre11 to Ku signal for all four treatments.
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PART-II 
3.2.  Introduction 
As discussed above the MRN complex plays a key role not only in D-NHEJ and 
HRR, but also in B-NHEJ [114] The above experiments indicate that PARP-1 and 
Mre11 interact, which is in agreement with results showing that accumulation of 
Mre11 and Nbs-1 at the sites of DNA damage requires PARP-1 [94]. Previous results 
from our group have shown Ku and PARP-1 competition for DNA ends and 
implicated histone H1 as a factor contributing to DSB repair by B-NHEJ. These 
results raise several important questions: (1) Does the competition for DNA ends 
between proteins belonging to different repair pathways determines how the cell 
decides which pathway to engage? (2) Is there a synergism in the function of histone 
H1, PARP-1 and the MRN complex in B-NHEJ? 
PARP-1, is a potential component of B-NHEJ and is thought to function together with 
XRCC1/DNA Ligase III and histone H1. As mentioned above, our results implicate 
histone H1 as an accessory factor of DNA Ligase III and thus a putative component 
of B-NHEJ. We, therefore, investigated whether the activity of PARP-1 is modified by 
histone H1. For this purpose, we designed an in vitro PARP-1 activity assay utilizing 
purified proteins (PARP-1 protein and histone H1).  
 
3.2.1.  Purification of PARP-1 protein 
To facilitate the analysis of possible interactions between PARP-1 and histone H1, 
we utilized purified recombinant PARP-1 and histone H1. As purified histone H1 was 
commercially available, we purified only PARP-1. For this purpose we expressed 
recombinant PARP-1 in Sf9 cells and purified the protein as outlined under Material 
and Methods. The initial purification strategy relied on affinity purification utilizing 
DNA cellulose resin, owing to the DNA binding properties of PARP-1. A step gradient 
elution scheme was established with a buffer containing 250-1000mM NaCl and 
bound proteins were eluted at 750mM NaCl. Fractions containing protein peaks were 
analyzed on SDS-PAGE (Figure 1.13). Indicated fractions (B1-B9) from first round of 
chromatography and were run on SDS-PAGE to determine the purity of PARP-1. 
Although affinity purification led to 80% purity of PARP-1, it was necessary to remove 
some low molecular weight contaminating proteins. Hence, a second step of 
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purification was included in the protocol. 
 In the second round of purification, we utilized gel filtration (size exclusion) 
chromatography to remove small molecular weight proteins. Fraction B7 from the 
affinity purification was selected for further purification by Gel Filtration. Indicated 
fractions (B5-B9) from the second round were analyzed on SDS-PAGE and Western 
blot to identify PARP-1 and determine purity (Figure 1.13). The fractions containing 
PARP-1 (B5-B9) were dialysed against CB buffer (300mM KCl), aliquoted and stored 
in -80°C. In further experiments, the enzymatic activity of PARP-1 was determined by 
using short radiolabeled DNA oligonucleotides and non-radioactive assays. 
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Figure 1.13  
Purification of PARP-1: 
A) SDS-PAGE of fractions collected after affinity chromatography. SDS-PAGE 
fractions from the corresponding peak in chromatogram (B1-B9). 
B) Representative chromatogram plot of affinity chromatography. Fractions (A1-A12) 
are wash and flow through fractions, and (B1-B12) were eluted from DNA 
cellulose column. X-axis denotes the volume (ml) of buffer passed through 
column and Y-axis denotes the UV absorbance (mAU) at 280nm. 
C) SDS-PAGE of fractions from gel filtration. Fractions from the Gel filtration column 
corresponding to the peak in the chromatogram (B5 –B9) were run on SDS PAGE 
and on a Western blot. The purity of PARP-1 (113kDa) after gel filtration is clearly 
seen.  
D) Representative chromatogram of PARP-1 gel filtration using sephadex 200.
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3.2.2.  Enzymatic activity of purified PARP-1 
To determine the activity of purified PARP-1, two functional assays were utilized. 
First, a non-radioactive Western blot assay which is based on the quantification of 
PARP-1 auto-poly–ADP-ribosylation using an anti-poly(ADP-ribose) antibody, and 
EMSA. Both assays are described under Materials and Methods. In presence of 
oligonucleotides, PARP-1 utilizes NAD+ as a substrate to ribosylate itself, thus 
causing the high molecular weight smear in the Western blot. The auto-ribosylation of 
PARP-1 is a post-translational modification recognized by the anti-poly-(ADP-ribose) 
antibody.  
Figure 1.14 illustrates the activity of PARP-1 under various conditions. The Figure 
shows PARP-1 activity (Figure 1.14 A and B) with increasing concentration of purified 
enzyme. Figures 1.14 C and D show that PARP-1 activity is influenced by the 
presence of oligonucleotides. As PARP-1 was purified from DNA cellulose column, 
the possibility of contamination with small fragments of DNA cannot be ruled out, 
which might explain the activity observed in the absence of oligonucleotides. PARP-1 
auto-poly–ADP-ribosylation increases with time and as shown in Figures 1.14 E and 
F, it increases significantly from 5 to 10 min reaching a plateau at later times. 
Increasing the concentration of NAD+ also increases PARP-1 auto-poly–ADP-
ribosylation (Figure 1.14 G and H). 
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Figure 1.14 
(A) Analysis of PARP-1 activity: 
A) Western blot showing PARP-1 activity when blotted with an anti-PAR Ab at 
four different PARP-1 concentrations in the presence of an oligonucleotide 
2 ng).  
B) Bar graph representing densitometric analysis of PAR signal intensity. 
C) PARP-1 auto-poly–ADP-ribosylation determined by Western blotting at 
different concentrations of oligonucleotides.  
D) Bar graph representing the values calculated from the signal intensity in C. 
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Figure 1.14 
Analysis of PARP-1 activity (Continued): 
E) Western blot showing PARP-1 auto-poly–ADP-ribosylation determined 
with an anti-PAR Ab at four different time points of incubation. 
F) Bar graph showing densitometric analysis of PAR signal intensity from 
E. 
G) PARP-1 auto-poly–ADP-ribosylation with increasing concentration of 
NAD+ in the presence of 2 ng oligonucleotides. 
H) Bar graph representing the values calculated from the signal intensity in 
G. 
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3.2.3.  PARP-1 activity determined by EMSA 
We employed EMSA to examine DNA end binding activity of purified PARP-1. PARP-
1 effectively binds a radioactively labeled double-stranded DNA oligonucleotide 
substrate causing a mobility shift that is clearly detectable above 1 pmol protein 
concentration. We chose blunt-ended oligonucleotide substrates (OA/OB) to test the 
enzymatic activity of our purified PARP-1. OA/OB avidly binds PARP-1 and gives a 
measurable shift at 0.2 pmol of oligonucleotide. Representative phosphor images of 
the EMSA experiments carried out under different conditions are summarized in 
Figure 1.15. The control reaction with free DNA alone shows a band at low molecular 
weight that migrates at the bottom of gel. On addition of purified PARP-1 to the 
reaction mixture containing the oligos, a significant shift in the oligos band is 
observed. To confirm that the DNA binding protein in our EMSA assays is PARP-1, 
the reactions were supplemented with anti-PARP-1 antibody. Binding of antibody to 
PARP-1 results in a super shift, identified as a slowly migrating band in Figure 1.15. 
As a control, we also used purified Ku to indicate shift and super-shift of bands, since 
both Ku and PARP-1 show the same pattern of shift and super-shift bands in EMSA. 
As a positive control, we used semi-purified, commercially-available PARP-1 from 
Biomol, which also shows the expected gel shift. Our purified PARP-1 displayed very 
high levels of activity and lead to the formation of complexes which were unable to 
enter the gel, (Figure 1.15). A super-shift was visible with our purified fraction when 
used at low concentrations (5ng).  
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Figure 1.15 
Analysis of PARP-1 activity by EMSA: 
EMSA gel depicting activity of PARP-1 when bound to oligonucleotides. Starting 
from left, the first lane shows signal of only radiolabeled oligonucleotide (25bp), 
the second depicts the signal of purified Ku when bound to the same 
oligonucleotide, next lane shows super-shift signal by an anti-Ku 80 Ab, the fourth 
lane shows Biomol PARP-1 bound to oligonucleotides, the fifth lane shows 
purified PARP-1 (5ng) when bound to oligonucleotides, next is with purified 
PARP-1 (5ng) plus an anti-PARP-1 antibody, the seventh lane is with purified 
PARP-1 (10ng) bound to oligonucleotides and the last lane shows purified PARP-
1 (10ng) with an anti-PARP-1 antibody bound to oligonucleotides. 
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3.2.4.  Histone H1 activates PARP-1 
Fractionation studies combined with proteomic analysis of active fractions identified 
histone H1 as a component of B-NHEJ, possibly functioning as an alignment factor or 
DNA end-joining factor [42]. This postulate is supported by the observation that DNA 
end ligation activity of LigIII is strongly and relatively specifically enhanced by histone 
H1. We inquired, therefore, whether the activity of other candidate components of 
this pathway such as PARP-1 is modified by histone H1. For this purpose, we 
assembled a reaction in the presence of NAD+ and different amounts of purified 
PARP-1 and its activity was measured using an antibody against poly-(ADP ribose). 
The results show a marked increase in PARP-1 activity with increasing concentration 
of histone H1, measured either by Western blot (Figure 1.16 A) or by dot blot (Figure 
1.16 B), although the increase was more evident in the dot blot. Thus, a marked 
stimulation is observed at low concentrations of histone H1 reaching a maximum at 
about 10 – 20 ng and a decline at higher concentration. These results indicate that 
histone H1 can markedly influence PARP-1 activity. 
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Figure 1.16 
(A) Histone H1 activates PARP-1(Western blot): 
A)  Western blot depicting PARP-1 activity measured by auto-poly-(ADP-
ribosylation), detected by an antibody against poly-(ADP-ribose) using 50 
ng of purified PARP-1.  
B)  Western blot detected by an anti-PAR Ab to evaluate PARP-1 activity 
using 100 ng of purified PARP-1. 
C)  Line graph representing the densitometric quantification of results shown 
in the corresponding blots. 
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Figure 1.16 
(B) Histone H1 activates PARP-1(Dot blot): 
 
A)  Dot Blot depicting PARP-1 activity which was measured by auto-poly-
(ADP-ribosylation) and detected by an antibody against poly-(ADP-ribose) 
using 50 and 100 ng of purified PARP-1. 
B)  Line graph representing the densitometric quantification of results shown 
in the corresponding blot.
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4.  Discussion 
The results presented here offer some novel insights into the role of Mre11 and Ku in 
DDR. The first part of the thesis focuses on the determination of the functional 
significance of the physical interaction between Mre11 and Ku and investigates 
whether this interaction is modulated by IR. The MRN complex is a well known 
sensor of DNA damage, functioning in signaling pathways that activate cell cycle 
checkpoints. Although the function of Mre11 is also known to be important for 
homologous recombination repair (HRR), recent studies have shown that this protein 
may have functions in non homologous end joining (D-NHEJ) as well. Indeed, in 
yeast, in addition to the Ku and Ligase IV homologs, also the MRN homologs are 
found to be involved in NHEJ. 
4.1.  Why Mre11 and Ku interact? What is the influence of IR on this 
interaction? 
MRN and Ku are among the earliest molecule which recognizes DNA double strand 
breaks. The interaction of mammalian Ku heterodimer and Mre11 has already been 
reported in somatic cells [55]. However, the order of assembly onto DSB ends, their 
relationship and interdependency, as well as the regulation of this interaction by IR or 
DNA damage is not well understood. Our results confirmed the interaction between 
Mre11 and Ku though IP with antibodies raised against either protein. The interaction 
is resistant to EtBr and RNase suggesting that it is does not derive from independent 
binding to DNA or RNA of the two DNA binding proteins.  
The crystal structure of Ku reveals an asymmetric ring conformation allowing the 
threading of the DNA that may facilitating the rejoining of the DNA ends. After 
completion of end joining, the Ku heterodimer is either immediately removed by 
degradation (ubiquitination), or it remains trapped, at least for some time, on the 
repaired DNA and may act as a marker or signal for subsequent steps of repair or 
signaling, including the possible recruitment of signaling factors such as MRN and 
possibly also of HRR components. In Saccharomyces cerevisiae, MRX facilitates 
NHEJ [127, 128]. To what extent mammalian MRN influences NHEJ of 
unprogrammed DSBs is not clear.  
In the present thesis, we test the hypothesis that the MRN complex plays a bridging 
role between HRR and NHEJ. In vertebrates, the MRN complex controls important 
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aspects of the DNA damage response, at least at the early signaling steps [129], but 
its possible role in NHEJ remains uncharacterized. Recent studies show that MRN 
may contribute to the Ku-dependent NHEJ in mammalian cell-free extracts and both 
proteins participate in a complex that is formed immediately prior to rejoining [43, 
130, 131]. It has been reported that silencing of Mre11 causes a reduction of NHEJ - 
both the classical and the alternative versions of the pathway [43]. There is also 
evidence that depletion of Mre11 suppresses end-resection in Xrcc4-/- /LigaseIV-/- 
cells indicating a role in B-NHEJ [113]. One study suggests that Mre11 functions in 
NHEJ as a scaffold to support synapsis between the DNA ends. As NHEJ does not 
entail extensive end-resection (except for a role of Artemis in a subset of DNA 
breaks), this could be a function of Mre11 in this pathway, thereby promoting the re-
ligation of a DSB [113, 132]. 
To address these issues in greater detail, we started by deciphering the interactions 
between Mre11 and Ku in cells exposed to IR. Our results clearly indicate that the 
interaction between Mre11 and Ku is DNA damage dependent and increases with 
increasing dose of IR. This suggests that both Mre11 and Ku are the earliest 
molecules to be recruited to DNA damage sites. Recent work from a group showed 
the accumulation of Mre11 in nuclear foci in human cells. Mre11 was found to be 
distributed throughout the nuclei of irradiated cells in CHO-K1-Xrs-6 cells, which are 
Ku80 deficient [55]. This suggests that Ku may be responsible for recruitment of 
Mre11 to DNA damage sites. Our experiments showed a dose- dependent interaction 
of Ku and Mre11 in wild type cells; of course this interaction was absent in Ku 
mutants. 
4.2.  Mre11 recruitment at DNA damage sites occurs within 10 min 
after IR 
Next, we studied the Ku/Mre11 kinetics of interaction at different time points after IR. 
We observed that KU/Mre11 interaction is observable within 10 minutes after IR, 
consistent with prior observations which were IR induced Mre11/Ku interaction and 
known interactions between Mre11 and Ku in yeast [108]. In yeast, YFP-Mre11 
recruitment was found to be the earliest detectable event at a DSB; it formed a focus 
peak within 6 min after IR. Also, delay in maximal MRX binding in the absence of Ku 
suggests a role of Ku in stabilizing MRX complex for NHEJ. However, it was also 
found that ligase binding strongly depends on Ku, while MRX loss only leads to a 
Discussion 
 - 81 -
 
delay in ligase binding. This allows the conclusion that Ku but not MTX is essential 
for the recruitment of ligase at the sites of DSBs [133, 134]. As a matter of fact, Ku 
and MRX binding were found to coexist immediately after the formation of a DSB, 
which might suggest that these proteins are not present in a preformed complex, but 
rather the binding of each might be intensified by the DSB substrate and the 
presence of the other. In yeast, it was also observed that the disappearance of Ku 
and DNA Ligase IV from unrepaired DSBs strongly depends on MRX, where a 
persistent signal of Ku was observed when MRX was not present [135]. Thus, MRN 
might be the factor responsible for post-translational modification of Ku, possibly also 
assisting in its unloading from repaired DNA. It has also been proposed that the 
removal of Ku happens by ubiquitination [50], but the mechanism is still unknown. 
4.3.  Players of Ku/Mre11 interaction 
Our results clearly show that not only Mre11 but also Nbs1 and Rad50 are 
constituents of the Ku/Mre11 interaction, thus implicating the whole MRN complex in 
the process. Since it is known that the MRN complex controls ATM activation [129, 
136], we thought of determining the possible role of ATM in this interaction. Notably, 
in the absence of ATM activity the interaction between Ku and Mre11 was abrogated. 
MRN was also recently found to be a prime candidate for B-NHEJ [113] raising the 
possibility that D-NHEJ and B-NHEJ share common steps. PARP-1 was also found 
to be present in the Ku/Mre11 complex providing thus further evidence for pathway 
cross talk and the possibility the Ku/Mre11 complex contributes to this phenomenon. 
It is known that DNA damage-dependent rapid accumulation of Mre11 and Nbs1 at 
the damage sites requires PARP-1, which provides further hints for DNA damage 
sensor protein cooperation [94]. Since Mre11 is known to interact with PARP-1 at the 
sites of DSBs [94], the role of Mre11 in B-NHEJ is also consistent with data that 
describe the role of PARP-1 in B-NHEJ [115, 137]. 
4.4.  How do DNA-PKcs and ATM influence the Mre11/Ku 
interaction? 
The DNA-PKcs is recruited to the Ku-DNA end complex to form the holoenzyme 
DNA-PK and activate the kinase. It was therefore reasonable to study the role of 
DNA-PKcs on the Mre11/Ku interaction. In vitro-studies show that DNA-PKcs 
phosphorylates both Ku and XRCC4 [131]. Autophosphorylation of DNA-PKcs also 
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appears to play a key role in NHEJ and is thought to induce a conformational change 
that allows end-processing enzymes to access the ends of the DSBs. However, 
phosphorylation could also modulate the interactions of Ku and XRCC4 with DNA-
PKcs itself, or with other regulatory proteins, probably including the constituents of 
MRN complex. The results generated showed that in the absence of DNA-PKcs the 
IR-mediated interaction between Mre11 and Ku is down regulated. 
As discussed earlier, the MRN complex is known to be involved in the activation of 
the ATM kinase in response to DSBs. Our results show the involvement of ATM 
kinase as well in the interaction of Ku with MRN. To analyze this interplay, we 
performed IP in ATM deficient cells and found a reduction of the IR-mediated 
Mre11/Ku interaction. Our data also suggests that Mre11 can affect NHEJ in an ATM 
dependent manner, as Mre11 could modulate end-joining by its nuclease-dependent 
or independent functions. Inhibition of ATM causes a delay in DNA repair [43] and 
there are reports which suggest that Mre11 can affect NHEJ, partly in an ATM 
dependent manner [43]. Thus, Mre11 could control end joining through both ATM 
dependent and ATM independent mechanisms [43].  
It has been reported that deletion of Nbs1 in MEFs completely abrogates ATM target 
phosphorylation in response to IR [138]. These observations and striking similarities 
between syndromes caused by mutations in ATM, Nbs1 and Mre11 are consistent 
with a sensor function for the MRN complex. As observed from our results and as 
discussed above, the probable regulators for the DNA damage dependent 
interactions between Mre11 and Ku seem to be the DNA-PKcs and ATM kinases.  
When we investigated in vitro the effect of phosphorylation and dephosphorylation on 
Mre11/Ku interaction, we observed that maintenance of phosphorylation retained the 
IR-dependent aspect of the interaction, whereas dephosphorylation completely 
abrogated the interaction.  
4.5.  How does phosphorylation influence the Mre11/Ku interaction? 
We suspected that the IR dose dependent interaction between Mre11 and Ku is 
regulated by phosphorylation, as phosphorylation sites are abundant in Ku and 
Mre11 (known as well as unknown sites). Our results suggest that phosphorylation is 
critical for the Mre11/Ku interaction, but that this effect is a dynamic process. When 
we checked by BAP, no dose dependent enhancement or decrease in the interaction 
was observed. On the other hand, when the interaction was checked by phosphatase 
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inhibitors, a decrease in the constitutive interaction was observed, but the IR dose 
dependent increase in the interaction was retained.  
Various reports provide valuable background information for this phenomenon. Thus, 
phosphorylation of SQ/TQ sites inactivates MRN and facilitates its dissociation from 
chromatin, thus allowing down regulation of DNA damage signalling and recovery 
from checkpoint response. According to this model, DSBs trigger rapid association 
coupled with the hyper-phosphorylation of Mre11. Hence, it is important to identify 
both proteins phosphorylated in response to DNA damage and the kinases 
responsible for this phosphorylation. As one report suggests that DNA-PK mediated 
phosphorylation of Ku is not required for DSB repair by NHEJ [139], the possible role 
of ATM/MRN as a main regulator is suggested. 
4.6.  Comparison of results from in vivo and in vitro systems  
Despite the fact that Ku has a central role in NHEJ, we still have an incomplete 
picture of the interaction between Ku and DNA. Studies of the affinity of Ku to various 
DNA configurations demonstrated that Ku binding is specific for single to double 
stranded transitions [59, 140]. After loading on DNA ends, Ku can diffuse to internal 
positions in an energy independent manner.[141]. Issues such as the interaction of 
Ku with DNA when DNA length is sufficient for more than one Ku molecule to load, 
have recently been resolved, suggesting that Ku binds cooperatively to DNA when 
the DNA has sufficient length to accommodate two Ku molecules and this is 
sequence independent. This model suggests that Ku molecules may function by 
providing more sites for recruiting other factors that participate in other aspects of the 
DDR [142].  
We also observed in in vitro experiments that Ku binding was directly proportional to 
the size of oligos when IP was performed with an anti-Mre11 Ab using A549 or Xrs-6 
NE. Interestingly, Ku showed this pattern of binding only in NE of A549 cells but not 
in Xrs-6 cells. This difference in the binding pattern of Ku leads us to suggest two 
different models; first, A549 NE mimics the in vivo situation where all the cellular 
components and signalling molecules facilitate the dose dependent interaction 
between Mre11 and Ku, and second, the less efficient in vitro artificial system used to 
study the interactions between purified Mre11 and Ku70. Our results suggest that 
dose dependent interactions between Ku and Mre11 may be dependent on other 
components and processes, which may not take place in some mutants. The 
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possibility of competition between Ku and Mre11 for DNA ends can also not be ruled 
out. Finally the large difference in the levels of DNA-PKcs between hamster and 
human systems, may contribute to the different responses observed. 
4.7.  Intertwining of NHEJ pathways 
When a DSB is induced in a repair proficient cell, the most likely scenario is that the 
Ku heterodimer will bind to the ends of the broken DNA replacing bound histone H1 
(in cooperation with DNA-PK) and possibly also other components of chromatin in 
preparation for the recruitment of DNA-PKcs to the site. DNA-PKcs dependent 
phosphorylation events then will regulate and coordinate the end-joining process and 
ultimately lead to end ligation catalyzed by LigaseIV/XRCC4/XLF complex, with a 
possible role of Artemis in a subset of breaks. Activation of DNA-PKcs is expected to 
facilitate the removal of histone H1 from chromatin and to facilitate the productive 
functions of Ku at DNA ends. 
If the DNA-PK-dependent pathway of NHEJ is compromised as a result of a defect in 
one of its components, histone H1 will probably remain bound and will act as an 
alignment factor to mediate end joining by LigaseIII/XRCC1 complex, possibly with 
the contribution of PARP-1. This pathway operates with slower kinetics and is 
normally suppressed by D-NHEJ. Regulation of DSB end processing via Ku/CtIP is a 
common step during B-NHEJ, SSA and HDR. Recently, it has also been shown that 
DSB end-processing factors Ku and CTIP affect all three pathways similarly. 
4.8.  How PARP-1 and histone H1 influence backup pathways? 
Little is known about the potential consequences of B-NHEJ function, about the 
underlying mechanism and its regulation. Here we show interaction between PARP-
1, Mre11 and Ku. Histone H1’s role in B-NHEJ and its effect on PARP-1 activity has 
been reported [42]. A marked stimulation is observed at low concentrations of histone 
H1 reaching a maximum at about 10-20 ng with a decline at higher concentrations. 
These observations point to a cooperative interaction between PARP-1 and histone 
H1, which is compatible with a function in the same repair pathway. The effect in our 
experiments, particularly for inhibitory concentrations of histone H1, suggests that 
PARP-1 may have a role in relieving local inhibition of DSB repair by histone H1. It 
has been shown that the end-ligation activity of DNA Ligase III is strongly and 
relatively specifically enhanced by histone H1, albeit in a narrow range of 
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concentrations [42], which also explains some reports of inhibitory action of histone 
H1. 
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5.  Concluding Remarks 
The major observations and conclusions that can be drawn from this study are 
as follows: 
In different types of cellular extracts we employed immunoprecipitation techniques to 
show the DNA damage dependent interaction between Mre11 and Ku.  
1. We provided evidence that the MRN complex and Ku, the earliest known molecules 
to sense DSBs, physically interact with each other. We also found that this interaction 
is IR dose dependent. 
2. We examined interdependency for this interaction and generated results suggesting 
that the Mre11/Ku interaction has a component that requires DNA and DNA damage, 
but also a component that is independent of DNA or DNA damage. We determined 
that the entire MRN complex is involved in this interaction, as well as PARP-1. 
3. We measured the kinetics of Mre11/Ku interaction and show it to be detectable 10 
min post irradiation. 
4. We provided evidence that the dose dependent interaction of Mre11 with Ku depends 
on the PIKK-3 group of kinase family members like DNA-PKcs and ATM. The decline 
in interaction observed in DNA-PKcs and ATM mutant cell lines hints to possible 
connections between these kinases and the Mre11/Ku interaction. 
5. Results from second part of the thesis helped in establishing that histone H1 
enhances the activity of PARP-1 protein, whose possible role in backup pathways of 
NHEJ (B-NHEJ) is already documented.  
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6.  Future Outlook 
The data presented in this thesis provide new insights into the role of MRN complex 
and Ku in the repair of DSBs, as well as the role of other repair and signaling proteins 
in DDR. DNA damage induction and repair are associated with activation of a myriad 
of proteins and their sequential recruitment to damage sites. Although a great deal is 
known about NHEJ, the most prominent and prompt but error prone DSB repair 
pathway, knowledge about the functional aspects of the individual participating 
proteins is still lacking. For example, the significance and purpose of the interaction 
of Ku with signaling molecules like the MRN complex is still unanswered.  
We speculate that this interaction could mediate post translation modifications in Ku 
leading to its unloading from the repaired DNA. This aspect of the interaction needs 
to be studied further. In addition, Mre11 and Ku interactions need to be studied in cell 
lines defective in individual MRN components using purified proteins with specific 
mutations that may help enlighten the specificity of this interaction.  
It would also be useful to use various drugs like Wortmannin or Mirin to inhibit the 
function of specific partners and to study further the interactions between them. To 
further illustrate the critical role of phosphorylation and dephosphorylation, phospho-
specific antibodies could be useful to determine activation and deactivation of 
proteins through their phosphorylation status immediately after DNA damage 
induction (IR) or during the repair process.  
At last, a detailed investigation of the potential link between D-NHEJ and B-
NHEJ, as well as the regulatory functions of proteins such as MRN complex, CtIP, 
PARP-1, histone H1 and LigaseIII/XRCC1 may prove useful in elucidating the DNA 
repair mechanisms and the factors affecting choice of a particular repair pathway by 
the cell. 
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8.  Appendix 
Buffers and Solutions 
 
Appendix 1: Cell flow cytometry and tissue culture 
1. 1X Phosphate Buffered Saline (PBS)  
     Dissolve the following in 800ml Double distilled water (ddH2O). 
 8 g of NaCl 
 0.2 g of KCl 
 1.44 g of Na2HPO4 
 0.24 g of KH2PO4  
 Adjust pH to 7.4, Adjust volume to 1L with additional ddH2O. Sterilize by 
autoclaving and store at 4°C. 
2. Trypsin-EDTA (Trypsin 0.05%, EDTA 0.02%) 
 0.5 g of Trypsin 
 0.2 g of EDTA 
 Adjust the volume to 1 L with 1X PBS. 
Sterilize by passing through 0.22 μm filter and store at -20 °C. 
3. Sodium azide (NaN3 0.02%) 
10 g of NaN3 
 Adjust the volume to 100 ml with ddH2O. 
Store at RT. 
4. BrdU stock solution (10mM) 
0.307 g of BrdU 
Adjust the volume to 100 ml with 1X PBS. 
Sterilize by passing through 0.22 μm filter and store at -20 °C in dark. 
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5. 100X Propidium iodide (4 mg/ml) 
400 mg of PI 
Adjust the volume to 100 ml with ddH2O.  
Store at -20°C in dark. 
6. 100X RNase (6.2 mg/ml) 
620 mg of BrdU 
Adjust the volume to 100 ml with MQ  
Store at -20°C in dark. 
7. 1M HCl 
Add 10 ml 12M HCl to 50 ml ddH2O. 
Adjust the volume to 120ml with ddH2O. 
Store at RT.  
 
Appendix 2: Electrophoresis 
8. 4x Tris/SDS pH 6.8 stacking gel buffer 
Dissolve 6.05 g Tris-base in 40ml ddH2O. 
Adjust pH to 6.8 with 1 N HCl. 
Add H20 to 100 ml. 
Add 0.4 g SDS. 
Store at 4°C. 
9. 4x Tris/SDS pH 8.8 resolving gel buffer 
Dissolve 91 g Tris-base in 300 ml ddH2O. 
Adjust to pH 8.8 with 1 N HCl. 
Add H2O to 500 ml. 
Add 2 g SDS. Store at room temperature  
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10.  5x SDS electrophoresis buffer 
15.1 g Tris-base 
72.0 g glycine 
5.0 g SDS 
Add ddH2O to 1000 ml. 
Store at room temperature.  
11. 6x SDS sample buffer 
7 ml 4x Tris/SDS pH 6.8 stacking gel buffer 
3.0 ml glycerol 
1 g SDS 
0.93 g DTT (dithio-threitol) 
1.2 mg bromophenol blue 
Add ddH2O to 10 ml. 
Store in 1 ml aliquots at -20°C.  
12. 1X Transfer Buffer (Western blot transfer buffer) 
Dissolve the following in 1600ml ddH2O. 
 28.8 g of glycine 
 6.04 g Tris base 
Add 200 ml methanol. 
Adjust the volume to 2000 ml with ddH2O. 
Store at 4°C. 
13. Tween-20 20%  
200 ml Tween-20 
Adjust the volume to 1000ml with ddH2O.  
Store the solution at RT in dark.  
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14. TBST (PBS-0.05% Tween-20, washing buffer)   
2.5 ml 20% Tween-20  
Adjust the volume to 1000 ml with PBS. 
Store the solution at RT in dark.  
15. PBST-milk (PBST-5% ,Tween-20, washing buffer)   
5g of milk (blot grade) 
Adjust the volume to 1000 ml with ddH2O. 
Store the solution at 4 °C in dark. 
16. Coommassie – staining Solution 
0.02% Coommassie Brilliant Blue G250 
2% (w/v) Phosphoric acid 
5% Aluminium sulphate 
10% Ethanol 
 
Appendix 3: Immunoprecipitation 
17. IP buffer 
           50mM Tris HCl pH 8.0 
           150mM NaCl 
           1% NP-40 (Igepal CA-630 ) 
18. True-Blot Buffer (TBST) 
50mMTris HCl pH 7.3 
150mM NaCl 
0.1 % Tween20 
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Appendix 4: Cell Fractionation 
       19. Hypotonic Buffer 
            10mM HEPES, pH 7.5  
            1.5mM MgCl2 
             5mM KCl 
             0.2mM PMSF 
             0.5mM DTT  
 
20. Low Salt Buffer 
 20mM HEPES, pH 7.9 at 4°C 
 1.5mM MgCl2 
 0.02M KCl  
 0.2mM EDTA  
 0.2mM PMSF 
 0.5mM DTT             
 
     21. High Salt Buffer 
10mM HEPES, pH 7.9 at 4°C 
1.6 M KCl 
1.5 mM MgCl2 
 
22. Dialysis Buffer 
25mM Tris/HCl pH 7.5 at 4°C 
10% Glycerol 
50mM EDTA 
1mM EDTA 
0.5 mM DTT 
0.2mM PMSF  
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Appendix 5: EMSA 
 
      23. 10X EMSA Buffer 
             10mM Tris-HCl, pH 7.5 
            1mM 
            1mM DTT 
            150 mM NaCl 
    
      24. 6% EMSA Non Denaturizing gel       
          Acrylamide/Bis acryl amide (30:1) - 10ml  
          0.5X TBE   (Stock-5X)                    - 5ml 
            H2O                                                - 35ml   
           10% APS                                        - 300µl 
           TEMED                                           - 90µl     
 
             25. 10X NHEJ Buffer 
               20mM Hepes-KOH (pH 7.5) 
               10mM MgCl2 
               80mM KCl 
               1mM ATP 
               1mM DTT 
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Appendix 6: Protein Purification 
  
26. PARP Purification Buffers        
      Homogenization Buffer 
      25mM Tris-HCl, pH 8.0 
      50mM Glucose 
      10mM EDTA 
      1mM β-mercaptoethanol 
      1mM DTT 
0.1mM PMSF 
      10% glycerol  
       
PARP chromatography Buffer A 
      50mM Tris-HCl, pH8.0 
      1mM EDTA 
      25mM Na2S2O3  
     10mM 2-Mercaptoethanol 
                 1mM DTT 
      0.1mM PMSF 
                 10% glycerol  
 
                  Buffer B  
                  Buffer A + 1M NaCl 
                           
       Dialysis Buffer 
                  0.25 M NaCl in Buffer A 
 
 
 
 
 
 
  
 
Appendix 
 - 103 -
 
27. Ku70/80 Purification buffers 
   
   Homogenization Buffer 
    50 mM Tris-HCl (pH 7.5)        
    100 mM NaCl         
    0.1% Igepal CA-630                                                                                                               
    2 mM EDTA 
    0.5 mM DTT          
    1 mM Phenylmethanesulfonyl fluoride (PMSF)    
    1 mM Benzamidine-HCl         
    1 µg/ml Leupeptin         
    2 µg/ml Aprotinin          
    1 µg/ml Pepstatin  
          
       
Ku-Chromatography Buffer A       
       50mM Tris-HCl, pH 7.9 
       1mM EDTA 
       0.02% Tween-20 
       5% Glycerol 
       1mM DTT 
       10ug/ml PMSF 
 
      Buffer B 
      Buffer A + 1M NaCl 
 
 
 
 
 
 
 
 
Acknowledgements 
 - 104 -
 
9.  Acknowledgements 
It is a pleasure to thank all the honorable people who have supported and inspired 
me in any respect in the completion of my thesis work. 
They say, success is a journey and not a destination. But I believe that the dream of 
success begins with a teacher who believes in you, who tugs and pushes and leads 
you to the next plateau, sometimes poking you with a sharp stick called "truth." And 
my journey of completion of thesis is no exception.  
I would like to express my deep and sincere gratitude to my supervisor, Professor Dr. 
George Iliakis, whose encouragement, guidance and support from the initial to the 
final level enabled me to develop an understanding of the subject and to complete 
my thesis. His wide knowledge and his logical way of thinking have been of great 
value for me. I thank him for providing me an opportunity to work under him by 
offering me this position in the institute. His detailed and constructive comments and 
his important support throughout this work have played a pivotal role in completion of 
this work. 
I would also like to thank Prof. Dr. Wolfgang-Ulrich Müller and Dr. Peter 
Tamulevicius for giving me insights into radiation protection, dosimetry and laboratory 
safety. 
I am extremely thankful to Frau Müller for her excellent and timely 
administrative assistance during my stay in the institute. 
I am very thankful to Dr. Bustanur Rosidi for introducing to me the basic 
principles of purification technique on ÄKTA FPLC system which helped me in 
studying various in-vitro aspects of the project. I would also like to convey my sincere 
thanks to Dr. Emil Mladenov who played an important role in getting my thesis 
completed. I am extremely grateful to him for his generous and timely help for my 
experiments. I would like to also thank Dr. Minli Wang for introducing various 
laboratory techniques in the lab in initial days of my Ph.D. thesis. 
I would like to thank Malihe Mesbah, Anita Hollenbeck, Tamara Musßfeldt, and Frau 
Lander for their constant wonderful technical assistance and endless effort in 
providing materials, chemicals and equipments needed for experimental purposes. I 
owe special thanks to all my past and present group members who helped and made 
our laboratory a convivial place to work. I would like to thank them all for their 
constant motivation and care extended during the years of my stay in Germany. 
Without their help and timely support this journey would have never been so 
Acknowledgements 
 - 105 -
 
pleasant. 
My deep regards to my Indian friends who have provided me a great company 
in Essen. Their social activities and moral support made my stay very congenial and 
convenient in this city. I extend my special thanks to Pooja, Savita, Pratima, Nisha, 
Preet, Aruna, Meenakshi, Pankaj, Janpriya, Satyendra, Aashish, Kunal, Shreenath, 
Manoj, Hemant. Special thanks to Janpriya and Satyendra who helped me in making 
appropriate corrections and in formatting my thesis. 
I would like to thank my loving parents and younger brother Bhavesh for their 
love and encouragement, as well as for supporting me in all my pursuits. 
Lastly, I offer my regards to all those who supported me in any respect during 
the completion of the project. 
The financial support of the University of Duisburg Essen is gratefully 
acknowledged. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Curriculum Vitae 
 - 106 -
 
10.  Curriculum Vitae 
Aparna Sharma 
             Institute for Medical Radiation Biology, 
      Medical School of University of Duisburg-Essen. 
                               Tel: 0176-24854260 
            ___ 
                                                                                                            
Personal Details 
 
Name:    Aparna Sharma  
Date of Birth:    December 12, 1980                            
E-mail address:  aparna.sharma@uk-essen.de 
 
 
Research Experience 
 
 
January 2006 onwards:  Ph.D. Student, Institute for Medical Radiation Biology (IFMSB), 
Medical School of University of Duisburg-Essen, Essen, 
Germany. 
 
2004 – 2005: Research Fellow, National Institute for Immunology, Jawaharlal 
Nehru University, New Delhi, India. 
 
2002 – 2003: Master Thesis dissertation titled “Cloning DHFR Gene in 
plasmid internal Ribosomal Entry Site Bicistronic Vector.” 
 
 
Education and Qualifications 
 
2001 – 2003: Masters in Biotechnology, Faculty of Life Sciences, Extol 
College, Barkatullah University, Bhopal, Madhya Pradesh, 
India. 
 
1999 – 2001:  Graduation in Basic Sciences, SRJ Girls Govt College, Vikram 
University, Ujjain, Madhya Pradesh, India. 
 
Until 1998:    Kendriya Vidyalaya, Neemuch, Madhya Pradesh, India.  
 
   
 
Curriculum Vitae 
 - 107 -
 
 Aparna Sharma 
             Institute for Medical Radiation Biology, 
      Medical School of University of Duisburg-Essen. 
                               Tel: 0176-24854260 
            ___ 
Training:  
 
2002 Summer training at Reliance Life Sciences, Mumbai under the 
guidance of Dr. Venkata Ramana, Associate Research 
Director. 
 
 
Accomplishments and Activities:  
 
2009 Participated in 12th GBS (Gesellschaft fuer Biologische 
Strahlenforschung) Jahrestagung, Essen. 
 
2003 Secured Third position in order of Merit in the University 
examination in M.Sc. Biotechnology. 
 
2002                              Won 1st prize in Extol TechnoGlimpse, Bhopal, India - an   
annual state level science model competition and exhibition on 
topic-“Cryopreservation”.  
 
 
 
Poster Presentation: 
 
12.Jahrestagung/12th Annual Conference Der/of the 
Gesellschaft für Biologische Strahlenforschung – GBS 30.9. – 
2.10.2009, Essen, Germany titled “DNA damage dependent 
interactions between Mre11 and Ku heterodimer.” 
 
 
Publications: 
 
 Rosidi B., Wang M., Wu W., Sharma A., Wang H., Iliakis G. 
“Histone H1 functions as a stimulatory factor in backup 
pathways of NHEJ.” Nucleic Acids research, 2008 Mar; 
36(5):1610-23 
 
 Singh S.M., Sharma A., Panda A.K. “High throughput 
purification of recombinant human growth hormone using radial 
flow chromatography.” Protein expression and Purification, 
2009 Nov; 68(1):54-9. 
 
 
  
Curriculum Vitae 
 - 108 -
 
 
  Aparna Sharma 
             Institute for Medical Radiation Biology, 
      Medical School of University of Duisburg-Essen. 
                               Tel: 0176-24854260 
            ___ 
Computer Knowledge:   
 
MS Windows                           
 
Microsoft Office  
 
BLAST, Vector NTI 
 
 
 
Languages Known: 
 
English   Fluent 
 
Hindi       Mother Tongue 
 
Hindi    Native language 
 
German   Basic knowledge 
 
 
 
 
 
 
 
 
Date: September 16, 2010                      Aparna Sharma 
 
 
  
 
 
 
 
 
 
 
 
Publications and Conferences 
 - 109 -
 
11.  Publications and Conferences 
 
Publications 
 
            1. Rosidi B., Wang M., Wu W., Sharma A., Wang H., Iliakis G. “Histone H1 functions 
as a stimulatory factor in backup pathways of NHEJ.” Nucleic Acids research, 2008 
Mar; 36(5):1610-23 
 
 2. Singh S.M., Sharma A., Panda A.K. “High throughput purification of recombinant 
human growth hormone using radial flow chromatography.” Protein expression and 
Purification, 2009 Nov; 68(1):54-9. 
 
 
 
 Poster Presentations 
 
12.Jahrestagung/12th Annual Conference Der/of the Gesellschaft für Biologische 
Strahlenforschung – GBS 30.9. – 2.10.2009, Essen, Germany titled “DNA damage 
dependent interactions between Mre11 and Ku heterodimer.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Declaration 
 - 110 -
 
12.  Declaration 
Erklärung:  
Hiermit erkläre ich, gem. § 6 Abs. 2, Nr. 7 der Promotionsordnung der Math.-Nat.- 
Fachbereiche zur Erlangung der Dr. rer. nat., dass ich das Arbeitgebiet, dem das 
Thema „Studies on Mre11-Ku interaction and its modulation by ionizing radiation“ 
zuzuordnen ist, in Forschung und Lehre vertrete und den Antrag von Frau Aparna 
Sharma befürworte.  
 
Essen, den ________  ____________________        _____________________ 
      Name des wissenschaftl.             Unterschrift d. wissenschaftl. 
      Betreuers/Mitglieds der             Betreuers/Mitglieds 
      Universität Duisburg-Essen          Universität Duisburg-Essen 
 
Erklärung:  
Hiermit erkläre ich, gem. § 6 Abs. 2, Nr. 6 der Promotionsordnung der Math.-Nat.- 
Fachbereiche zur Erlangung des Dr. rer. nat., dass ich die vorliegende Dissertation 
selbständig verfasst und mich keiner anderen als der angegebenen Hilfsmittel 
bedient habe.  
 
Essen, den _________________     ______________________________  
        Unterschrift des/r Doktoranden/in  
 
Erklärung:  
Hiermit erkläre ich, gem. § 6 Abs. 2, Nr. 8 der Promotionsordnung der Math.-Nat.- 
Fachbereiche zur Erlangung des Dr. rer. nat., dass ich keine anderen Promotionen 
bzw. Promotionsversuche in der Vergangenheit durchgeführt habe und dass diese 
Arbeit von keiner anderen Fakultät abgelehnt worden ist.  
 
 
Essen, den _________________       ______________________________ 
            Unterschrift des Doktoranden  
 
